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ABSTRACT
     We used variable number tandem repeats (VNTR) to validate the chicken as a human 
medical model for Pulmonary Arterial Hypertension. We identified seven regions on four 
chromosomes and interrogated for VNTR markers that significantly associate with 
Pulmonary Hypertension Syndrome/ascites. In those regions, we identified 7 candidate 
genes; AGTR1, ACE, p38MAPK, SST, 5HT2B, NET1, and CALM3 for further analysis as 
significantly contributing QTL for ascites/PHS.  We also used variable number tandem 
repeats to measure gene flow and gather evidence for multiple paternity in a population of 
Timber rattlesnakes, Crotalus horridus. We were able to verify 1 VNTR that can be used to 
assess gene flow in and among our populations. We were also able to use this VNTR to 
provide evidence of multiple paternity in the Timber rattlesnake. 
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INTRODUCTION
    Publication of the full genome sequences of multiple organisms has allowed the 
development of multiple avenues by which the genome can be analyzed. Variable number 
tandem repeat (VNTR) genotyping is one such tool. Long stretches of short, repetitive 
sequences can serve as biomarkers to track gene flow, identify mutation rates, locate genes 
contributing to the pathology of a disease, and more. This work presents the application of 
VNTR genotyping as a tool for identification of genes contributing to disease and as a tool 
for the analysis of the gene flow within and among a population of threatened animals.
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Chapter 1: Genetic Analysis of Chromosomal Regions Associated with Ascites in the 
Chicken: Literature Review
Ascites and Pulmonary Arterial Hypertension
     Ascites is an industry term for a metabolic condition of the cardiopulmonary system of 
broiler chickens that is associated with a fast growth rate and mortality in older birds 
(Pavlidis 2007). Ascites is more accurately known as pulmonary arterial hypertension 
(PAH) or Pulmonary Hypertension Syndrome (PHS) which are diseases shown to affect 
rats, pigs, and humans (Naeiji 2007, Robbins 2004). The genes involved in resistance and 
susceptibility to PAH are not yet fully described. Pulmonary arterial hypertension is also 
observed in the human population. In humans, it is comprised of a group of disorders with 
varying etiologies and underlying conditions. It is known as both a symptom of disease 
(secondary pulmonary hypertension) and a disease of its own right (primary pulmonary 
hypertension).   Our work addresses this polygenic trait through quantitative trait locus 
(QTL) analysis to identify candidate genes that contribute to the disease. 
     Ascites/PAH is a multi-symptom disease, affecting both the heart muscle and the 
vasculature of the bird (Wideman 2006). Pulmonary arterial hypertension is caused by an 
insufficient cardiopulmonary response to rapid growth of muscle mass. Initially, when 
subjected to pulmonary challenge, blood pressure rises as the cardiovascular system 
constricts vessels to increase flow to tissues. When this response is sustained over time, 
increased total blood volume, blood pressure, and red blood cell count (polycythemia) to 
supply the increased tissue mass with oxygen are observed. This uptick in blood volume 
results in right heart growth (hypertrophy) which further increases the pulmonary pressure 
and can result in hepatic damage and plasma accumulation to the abdomen. Abdominal 
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fluid resulting from hepatic damage is referred to as “ascites” which has become the name 
of PAH/PHS in poultry. 
     Currently, it is estimated that ascites-related mortality costs the poultry industry 
worldwide more than $500 billion per year (Katanbaf 2009). The poultry industry offsets 
the problems associated with PAH/ascites with protocols that alter growth rate and improve 
air quality. Feed restriction, used to control growth rate and good ventilation, used to 
reduce the respiratory strain on the cardiopulmonary system (Ozkan 2006) are effective 
tools, yet PAH remains a concern for the poultry industry. The possibility of genetic 
selection to eliminate PAH development in production birds is a tantalizing prospect that 
would permit an alternative and more cost effective control strategy for the rapid growth of 
broilers. 
     The poultry industry has a specific interest in the genetics of PAH/ascites because 
broiler birds are susceptible to the disease. Broilers are genetically selected for high growth 
rates and efficient feed conversion to allow for the rapid accumulation of body mass. Rapid 
increase in body mass without a concomitant increase in cardio-pulmonary output can lead 
to hypoxia in the bird, triggering an increase in cardio-pulmonary pressure to meet oxygen 
requirements of the tissues (Julian 2000). Ascites affects the poultry industry worldwide, 
but is more prevalent at high altitudes and regions where ventilation of bird houses is 
problematic (McMullin 2004). Ascites averages a 1-5% morbidity rate and a 1-2% 
mortality rate that can increase up to 30% at high altitude. Currently, ascites is managed in 
commercial flocks by feed restriction, but with this practice comes limited growth rate; 
consequently, feed intake must be carefully monitored and imposed upon flocks at strategic 
points along their life-span to allow concomitant maximum growth rate and lowered ascites 
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incidence (Ballay 1992, Yu 1992). The selection of breeding lines based on genetic 
markers is known as marker-assisted selection. The use of marker-assisted selection in 
tandem with phenotypic selection against susceptibility to ascites would allow for more 
streamlined breeding practices and presents the possibility for intervention at an earlier life 
stage in the animals. 
     The vascular system in chickens is made of resistance-sensitive vessels that respond to 
changes in pressure and air quality with constriction, dilation, or structural change 
(Gibbons and Dzau 1994). There are three layers to each of these vessels: the intima, made 
of endothelial cells; the media, made of smooth muscle cells; and the adventitia which is 
made of connective tissue elements and nerve tissues. The increase and decrease of 
vascular pressure leads to an increase or decrease of shear stress within the vessels which 
serves as a physical signal to the endothelial cells to begin proliferation and modification of 
vessel structure, specifically, the proliferation of smooth muscle cells. Proliferation in the 
vessels is an essential response to stimuli and is mandated by the need for vessels to 
maintain a dynamic response to an increase in pressure with a thickening of their walls to 
contain blood. Tissue modification in response to the dynamics of blood pressure is 
referred to as vascular remodeling which requires at least four cellular processes: cell 
growth, apoptosis, cell migration, and the restructuring (degradation and production) of the 
extracellular matrix. 
    The respiratory system of the chicken is heterogeneous and functionally segregated, with 
roughly 90% of the respiratory system of a bird being comprised of air sacs, which do not 
have much capacity for expansion beyond their normal inflation and act as a bellows to 
ventilate the lungs (Whittow 2000). The lungs are fixed and rigid with little capacity for 
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expansion to accommodate any rapid increase in blood volume. The parabronchi, which 
contain the air capillaries where gas exchange takes place, utilize an efficient cross-current 
model juxtaposing ventilation and perfusion at a right angle (Powell 2004). When 
compared to its progenitor, the Red Jungle Fowl (Moiseyeva 2003), the domestic broiler 
chicken has reduced lung volume and a thickened blood-gas tissue barrier, both of which 
present a challenge for efficient oxygen supply to tissues (Vidyadaran 1990). Research 
comparing broilers and layers has shown that there is a significant association between 
ascites and decreased relative size and function of lung, heart, and thoracic cavity. Broilers 
have greatly reduced cardiothoracic capacity as a percentage of weight when compared to 
leghorns (Hassanzadeh 2005, Martinez-Lemus 1998). Therefore, the consequences of 
selective breeding practices have led to a whole line of birds (broilers) whose oxygen 
requirements are only marginally met by their anatomy.
     The pathobiology of PAH involves complex biochemical pathways for growth and 
vascular tone regulation. The growth of cardiac muscle and development of hypertrophy 
requires proliferation of smooth muscle and connective tissue; these processes necessitate 
growth factors that must be up-regulated for quick growth. Fibroblast growth factor I 
(FGF1) has been shown to induce angiogenesis and proliferation of capillary endothelial 
cells in vivo (Montesano 1986). Transforming growth factor beta (TGFβ) has been shown 
to induce pathologic myocardial fibrosis (Campbell 1997). Platelet derived growth factor 
(PDGF) has been implicated as a modulator of myogenesis (Yablonka-Reuveni 2008).  If 
oxygen availability to an animal is significantly reduced, there is an immediate contraction 
of the pulmonary arterioles, presumably in an effort to preferentially provide vital organs 
with oxygen and an increase in blood volume to carry it. The immediate result is elevated 
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pulmonary arterial pressure. Elevated pressure, if protracted, induces a proliferative effect 
that results in the heart walls thickening and the ventricles becoming larger. Hypertrophy 
and persistent elevated pressure can often lead to valvular insufficiency which allows back 
flow of blood in the heart. Unlike striated muscle, there is no stem cell population to allow 
an adult heart to regenerate myocytes (Mima 1995). Sustained elevated pressure results in a 
parallel addition of sarcomeres in an effort to increase heart wall thickness (Hunter and 
Chien, 1999). Increased blood volume results in sequential addition of sarcomeres to 
lengthen myocytes and increase the size of the chamber (Julian 2007). Lack of oxygen 
results in myocyte death and the remaining myocytes are stretched ultimately leading to 
hypertrophy of the stressed right heart. Simply, there is an increase in heart muscle density 
but not contractile ability which can lead to the heart not emptying completely when it 
contracts, continued myocyte death, and significant congestion. The growth of the heart in 
response to elevated pressure and increasing blood volume further exacerbates the stress on 
the cardiopulmonary system. Growth factors play an intrinsic role in allowing this growth 
to occur in both smooth muscle cells and connective tissues, but they are not fully 
responsible for the damage done by PAH.
     Platelet dysfunction is often observed in tandem with PAH. Platelets appear to be 
activated in the progress of PAH, aggregate at the site of endothelial damage in the vessels 
due to elevated pressure, and exacerbate vasoconstriction by depositing serotonin into an 
already constricted system of vessels (Chaouat 1996, Humbert 2004, Eddahibi 2001). A 
study in 2004 compared the relative balance of vasodilators (nitric oxide, prostacyclin, and 
vascular endothelial growth factor) and vasoconstrictors (thromboxane A, serotonin, and 
endothelin-1) in broilers challenged with lipopolysaccharide (Wideman 2004). They found 
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that the hypertensive response is modulated when more vasodilators than vasoconstrictors 
were generated by the animal. Accordingly, they posited that innate differences in chemical 
response by the animal may have a key role in the response to vascular pulmonary 
challenge and/or pulmonary hypertension. The vascular response and homeostatic balance 
of these vasoactive substances is well studied in birds (Stebel 2008, Chapman 2006 and 
2008).
      In humans, PAH is divided into several different forms by the American Lung 
Association: associated, familial, and idiopathic pulmonary arterial hypertension (APAH, 
FPAH, and IPAH, respectively), PAH associated with venous or capillary compromise, and 
PAH of the newly born (Simonneau 2004). Secondary pulmonary hypertension includes 
FPAH and APAH which are often observed in patients with chronic obstructive pulmonary 
disease (COPD), congenital heart disease, AIDS, lupus, and other hypoventilation 
disorders. The familial form of PAH applies to cases where a family history of PAH can be 
established. Idiopathic PAH is also known as primary pulmonary hypertension (PPH), 
which is an exclusionary term that is applied to any case of pulmonary hypertension with 
no known cause (Rich 2000).
     All forms of PAH in humans display right ventricular hypertrophy, elevated pulmonary 
pressure, fatigue, chest pain, shortness of breath, plexiform lesions, and eventually, right 
ventricular failure (RVF) (Tuder 1998, Rubin 1997).  Plexiform lesions are conspicuous 
complex vascular lesions within the lungs. The lesions show signs of disordered 
endothelial proliferation. As PAH progresses, more and more plexiform lesions are 
observed, leading to successive lobe failure. There is currently no cure for PAH and 
patients face a poor prognosis, with a mortality rate around 50% at five years after 
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diagnosis (NHLBI Index 2009). The current treatments include anticoagulants, 
vasodilators, and lung transplantation, (Fukumoto 2007, Rubin 1990, Ghofrani 2003, 
Farber 2004) but none of these works to counteract the underlying cause, namely, cardiac 
hypertrophy and diminished lung capacity. 
     We propose the chicken as a medical model for human IPAH. The fawn-hooded rat is 
commonly used as a model for PAH (Muramatsu 2001). The rat is a well established as a 
model organism. However, the chicken is economical, can be selected for phenotype, has a 
completed genome, and ascites/PAH is easily induced.  Moreover, PAH is a commercial 
concern for the poultry industry as breeding practices for meat birds have exacerbated 
susceptibility for PAH. The chicken, in contrast to the rat, has been shown to 
spontaneously develop lesions indistinguishable from plexiform lesions observed in the 
human lung (Wideman 2009, Hamal 2009).  Additionally, leukocyte recruitment studies 
suggest that the immune response in the chicken may more closely mirror the human 
response to pulmonary challenge than that shown in the rat (Tuder 1994). Specifically, in 
rats, a high number of macrophages and a few lymphocytes localize to the site of 
inflammation upon micro-particle injection (Cook 1989, Cook 1990). Alternatively, when 
injected into chickens, micro-particles induce inflammation and recruitment of high 
numbers of lymphocytes and some macrophages. This lymphocyte population closely 
mirrors the populations observed when human plexiform lesions were analyzed (Tuder 
1994). 
     While it is of concern that the chicken and the human diverged somewhere between 
471-315 million years ago (Grauer 2004) and the lung of the chicken is anatomically 
different than that of mammals, there is also significant similarity in both the biochemical 
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regulation of pulmonary pressure and the anatomy of the heart (Whittow 2000). The genes 
presented in this work are functionally relevant to vascular regulation in both mammals and 
avian species.
     The underlying physiology of PAH in the chicken appears to be similar to the disorder 
in humans. PAH is easily induced in the broiler by elevated growth rate, lipopolysaccharide 
injection, microparticle injection, high altitude, poor ventilation, or growth in a hypobaric 
chamber (Chapman 2005, Balog 2000). The ease with which disease can be induced, the 
ease of breeding for a trait, a similar genome to the human (Groenen 2000), and 
spontaneous lesion formation (Wideman 2009) all make the chicken an ideal model 
organism for study of the genetics and subsequently the molecular physiology of 
PAH/IPAH in humans 
    Molecular analysis of PAH in humans presents a challenge due to the various forms of 
the condition. Identification of candidate genes is typically conducted in an ontological 
manner, with the function of known genes related to characteristics of the disease meriting 
investigation first. PAH involves many tissues, chemical signals, and processes. It has 
therefore been challenging to ontologically assign candidate genes for analysis, though 
some QTL are known in humans (Lifton 2001, Chung 2009).  However, all forms of PAH 
involve remodeling of smooth muscle and pulmonary arteries and in many forms of the 
disease involve endothelial cell proliferation, inflammatory response, and platelet 
dysfunction (Humbert 2004). Recently, the study of single nucleotide polymorphisms 
(SNPs) in IPAH patients has revealed that the genes for angiotensin type II receptor I 
(AGTR1) are associated with PAH (Chung 2009).  Chung et al observed that specific 
variants of the AGTR1 gene were significantly associated with late-onset PAH which 
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suggests a role for the renin-angiotensin-aldosterone system as an involved pathway in the 
progression of PAH. Additionally, the role of serotonin and its receptors in PAH have been 
extensively studied in recent years. A review published in 2009 indicated association of 
particular alleles of serotonin and its receptors 5HT2b and 5HT1b with PAH (MacLean 
2009). Specifically, over-expression of serotonin receptors is associated with heightened 
vasoconstriction and aggravated PAH symptoms.
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Genetic Mapping of PAH in the Chicken
    Surveying genomes to identify genes involved in disease is one of the most prevalent 
applications of modern molecular genetics today. One of the simplest forms of genome 
mapping is the utilization of variable number tandem repeats (VNTRs) as heritable markers 
for genetic variation (Mousseau 1998). VNTRs are stretches of repeats typically 1-6 base 
pairs repeated in tandem arrays for as many as hundreds of copies. The repeat number of 
these nucleotides can vary due to recombination or errors in replication. Variants for the 
repeat (different “alleles”) can be used to distinguish chromosomes based on the alleles 
inherited (genotype). Additionally, VNTRs serve as excellent markers for a genotype as 
they are linked to and inherited with genes in close proximity. Polymerase chain reaction 
(PCR) allows for simple and straight-forward amplification of the repeats. PCR products 
are easily resolved on polyacrylamide gels or by capillary electrophoresis. Fluorescent tags 
on the PCR primers allow for high-sensitivity detection, high-throughput genotyping of 
many individuals. Subsequent comparison of genotype to phenotype profiles allows 
elucidation of VNTR alleles or genotypes that are significantly associated with a phenotype 
of interest. 
     Quantitative genetics defines quantitative trait loci as contributors to a polygenic trait. 
For most traits, many loci contribute small effects that lead to a particular phenotype 
(Jansen 1994). Inbred lines of animals have been extensively mapped for QTL. These 
plants and animals can exhibit pronounced phenotypes that are readily quantified. Within 
an inbred population, examination of a trait, such as flower color, allows for identification 
of loci for that trait and obvious phenotypic change if that locus (loci) is manipulated 
(Lynch and Walsh 1998). Within a species, this mapping technique comparing phenotype 
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to genotype is especially effective. But there are currently few examples of homologous 
QTL between two organisms (Flint 2009).  
     While a single locus can often be attributed to a trait, the power of QTL analysis lies in 
the identification of multiple loci contributing to the effect. A study in 2004 evaluated the 
effect of multi-locus involvement of 13 polymorphisms of 8 candidate genes, including 
genes for angiotensin II type 1 receptor and angiotensin converting enzyme (ACE) when 
compared to single gene effects (Williams 2004). The study supported a model that 
required multiple pathway involvement to predispose an individual to hypertension. A 
multi-locus approach is especially important in diseases where multiple biochemical 
pathways contribute to symptoms and pathology, such as hypertension. As such, it is 
necessary to categorize PAH as a QTL disease and to approach candidate gene analyses 
from a polygenic perspective.  
     We have utilized resistant and susceptible sub-populations from a susceptible line of 
birds reared in a hypobaric chamber (Pavlidis 2007). The divergent selection used to 
develop this susceptible line was also used to develop a resistant line, distinguishable from 
the susceptible line by divergent ascites development, livability, right ventricle: total 
ventricle weight comparison (RV:TV), and body weight at 42 days. Our study aims to 
identify molecular markers linked to resistance and susceptibility between resistant and 
susceptible animals within the susceptible sub-population. 
     For this portion of the dissertation, we present the evidence of the evaluation of 7 
chromosomal regions previously identified as possibly associated with ascites 
susceptibility and cardiac hypertrophy. These regions were identified in a whole genome 
SNP analysis of an F1·F2 population from a cross between an ascites resistant and ascites 
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susceptible line. We developed VNTR markers for those chromosomal regions and 
genotyped susceptible and resistant birds from the susceptible line. This work confirmed 5 
regions on 4 chromosomes as associated with ascites susceptibility.
13
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Chapter 2: Genetic Analysis of Chromosomal Regions Associated with Ascites in the 
Chicken.
 
ABSTRACT We used a genome-wide single nucleotide polymorphism survey to identify 
7 chromosomal regions that showed linkage disequilibrium with respect to ascites 
susceptibility and ventricular hypertrophy. We then used variable number tandem repeats 
to obtain genotype data for these 7 regions in a separate, larger population sample 
segregating for ascites susceptibility. We analyzed the data for allele and genotype 
frequencies, and, where applicable, combined multiple loci to derive haplotypes associated 
with ascites.  We validated two regions on Gga9 and one region each on Gga1 and Gga27 
for involvement in ascites.  Probable candidate genes have been identified within these 
regions that also relate to pulmonary arterial hypertension in humans.  This work further 
validates the chicken as a medical model for human pulmonary arterial hypertension and 
identifies potential loci for selection against ascites in the chicken. 
INTRODUCTION 
     Idiopathic pulmonary arterial hypertension (IPAH) is one of five types of pulmonary 
hypertension recognized by the American Lung Association. It is characterized in humans 
by right ventricular hypertrophy, elevated pulmonary arterial pressure, fatigue, chest pain, 
shortness of breath, and ultimately, right ventricular failure (RVF). Our group has been 
investigating the genetics of ascites susceptibility and whether ascites approximates IPAH 
in humans. Ascites is a commercial concern for the poultry broiler industry and the ability 
to genetically select populations based on resistance to the disease is of interest to breeders. 
Selection for meat production through higher feed conversion efficiency and rapid 
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production of body mass has increased demands on the cardiovascular system to support 
the growing tissues (Wideman 2001). Application of genetic analysis of Pulmonary 
Hypertension Syndrome (PHS) in the chicken will result in better selection processes for 
the poultry industry and complementary molecular data for better screening, treatment, and 
evaluation of the chicken as a model for IPAH in humans. Here, we present data 
confirming multiple chromosomal regions for linkage disequilibrium of segregation 
relative to ascites resistance or susceptibility in this population.
METHODS  
     Experimental Population: Resistant and susceptible birds from the susceptible line 
(Pavlidis 2007) were reared under ideal conditions of lighting, temperature, and ventilation 
and received ad libitum food unless compromised by ascites development (Wideman 
2003). Birds were rescued with furosemide and/or feed restriction upon onset of PHS. All 
birds were evaluated for resistance or susceptibility to ascites using right ventricle to total 
ventricle (RV/TV) weight and electrocardiogram evaluation. Lead II ECGs were used to 
evaluate all birds for onset of PHS. Birds with relatively small and equal R and S wave 
amplitudes were considered to be clinically healthy. Birds with a small or non-existent R 
wave amplitude combined with a large, deeply negative S wave amplitude were considered 
to be pre-ascitic. Birds that developed clinical PHS/ascites were rescued by diuretic 
furosemide, skip-a-day feeding, and light restriction. RV/TV ratios were done post-mortem 
to confirm right heart hypertrophy in the ascitic birds.
     Isolation of DNA: A lancet was used to puncture a wing vein.  Twenty μl of blood was 
pipetted into 400 μl of STM (64 mM sucrose, 20 mM Tris Cl, pH 7.5, 10 mM MgCl2, and 
0.5% Triton X-100) for DNA isolation by the method of Bailes 2007.
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     Primer Design: VNTR (variable number tandem repeat) sequences were identified 
using the UCSC genome browser. PCR primer pairs were designed using Primer3 
(http://frodo.wi.mit.edu/) or PrimerSelect (DNAStar ver 6.0). Primer pairs were designed to 
satisfy the following criteria: 18-30 nucleotides in length, 40-60% GC content, 40-72° C 
Tm, and product length of approximately100-300 base pairs. Primer pairs were synthesized 
(MWG Biotech) and fluorescently labeled on the 5’ end of the forward primer with Cy3, 
Cy5, FAM, or HEX.  
     Polymerase Chain Reaction: PCR was performed in 96 well plates using either an MJ 
Research PTC-100 thermocycler or an Eppendorf Mastercycler gradient. Reactions (20ul) 
contained 1X Taq Buffer (50 mM Tris-Cl (pH 8.3), 1mM MgCl2, 30ug/ml BSA), 0.2 mM 
dNTPs, 0.4 uM each forward and reverse primers, 2.5 units Taq polymerase, and 2 μl of 
DNA (approx. 50 ng). PCR conditions were an initial denaturation at 90°C for 1 minute 
followed by 40-45 cycles of 90°C for 25 s, 30 s anneal temperature (Table 1), 72°C for 60 
s, and a final extension at 72°C for 3 minutes.
     Gel Electrophoresis:  PCR products were resolved in 6% denaturing polyacrylamide 
gels (38:2 acrylamide:MBA, 50% urea) in 1xTEB (100 mM Tris, 10 mM boric acid, 2 mM 
EDTA, pH 9.2). PCR product (2ul) was mixed with 5ul loading buffer (95% formamide, 
1X TEB, 0.02% bromophenol blue). Samples were heat denatured at 90° C for 5 minutes, 
quick chilled on ice, and then 1-2 μl was loaded per lane. CXR ladder (Promega Corp.) was 
used as size marker. 
     Gel Imaging: Gels were scanned with a Model 9600 Typhoon imager (GE Health Care) 
and images analyzed using ImageQuant software. 
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     Statistical Methods: Genotype and allele counts were analyzed in MS Excel. Expected 
genotype counts were calculated according to standard Hardy-Weinberg distributions. 
Expected allele frequencies for a sub population were calculated based on the allele 
frequency observed in the entire population.  For each allele, genotype, or haplotype we 
calculated P-values using the chi-test function to determine where observed differed from 
expected for either or both of the resistant and susceptible.  
RESULTS
     A genome wide single nucleotide polymorphism (SNP) panel was conducted in 2006 
(Cheng 2006). We were able to include 183 DNAs representing F1 and F2 birds from a 
cross between our ascites resistant and susceptible lines (Pavlidis 2007). For our samples, 
970 SNPs were uninformative while 1763 were polymorphic.  We analyzed SNP 
frequencies with respect to low vs. high RV/TV (hypertrophy) and resistance vs. 
susceptibility to ascites. The data was analyzed by Chi square to detect deviation of 
observed from expected for both ascites and RV/TV.  We then selected regions where 
successive SNPs deviated (P<0.01) for both traits with minor allele frequencies greater 
than 0.20.  This analysis identified at least 7 regions on 4 chromosomes; 0.64-1.05 Mbp, 
18.38-21.48 Mbp, and 127.01-128.3 Mbp on Gga1; 13.5-15 Mbp and 15.5-16.28 Mbp on 
Gga9; 2.04-2.32 Mbp on Gga27; and 47.12-48.98 Mbp on GgaZ as containing probable 
QTL affecting RV/TV and ascites.  We designed PCR primers to analyze one or more 
VNTRs in each of these 7 regions for further linkage analyses. 
     We generated a new test population consisting of 35 resistant females, 40 susceptible 
females, 56 resistant males, and 54 susceptible males from our susceptible line. Six 
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resistant birds of unknown sex were also included. All individuals were genotyped for all 7 
regions identified from the original SNP panel using 13 different primer pairs (Table 1).
     The region on Gga9 from 13.5-15.0 Mbp was interrogated with three primer pairs, 
PHS015, PHS009, and PHS010. PHS009 and PHS015 amplified three alleles each with 
PHS009 amplifying one allele of 275bp that was significantly under-represented in the 
resistant and over-represented in the susceptible sub-population (35.0 v.s. 24.5%, P=0.055) 
(Table 2). PHS010 amplified two alleles at approximately the same frequencies between 
the two sub-populations with the 161 bp allele being the most prevalent over all. 
Discrimination approaching significance for this VNTR was present at the genotypic level 
(Table 3) with the 151/151 homozygote being most associated with susceptibility (8.4 v.s. 
4.7%, P<0.03). The 161/151 genotype was nearly equally distributed, as was the 160/160. 
Owing to the low number of alleles and the overabundance of allele 161 at locus PHS010, 
we combined the data for the three markers in this region into haplotypes combining 
PHS015 with PHS009 and PHS009 with PHS010. We combined PHS015 with PHS009 
and generated haplotypes for 49 resistant 61 susceptible animals. There was no significant 
difference between the sub-populations for PHS015+PHS009. We were able to combine 
PHS009 and PHS010 for probable haplotypes for 68 resistant and 76 susceptible animals. 
This combination yielded one significant haplotype and one haplotype that approached 
significance. The 277-151 haplotype approaches significance and is over-represented in the 
susceptible sub-population and under-represented in the resistant sub-population (7.9 v.s. 
2.9%, P=0.075). The 275-161 haplotype is over-represented in the resistant and under-
represented in the susceptible sub-populations (38.2 v.s. 23.7%, P<0.026). The 
combination of all three markers PHS009+PHS015+PHS010 did not yield any haplotypes 
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that discriminated the sub-populations. However, the combination of PHS009 and PHS010 
is sufficient to differentiate our sub-populations.
     The region on Gga9 from 15.5-16.28 Mbp was evaluated with two primer pairs, 
PHS152 and PHS001. PHS152 amplified two alleles of 182 and 198 bp that did not differ 
significantly from expected frequencies for either the resistant or susceptible populations 
(Table 2). However, the 198/198 genotype was over-represented in the resistants (29 v.s. 
17%; P<0.04). PHS001 amplified 5 alleles between 139-157 bp approximating expected 
allele frequencies. The 155/155 genotype was observed nearly twice as often in the 
susceptible birds as in the resistant (21 v.s. 12%; P<0.04). Conversely, the 147/139 
genotype was observed more than twice as often in the resistant sub-population (21.1 v.s. 
10.4%; P<0.005). We could combine these two markers for 64 resistant and 66 susceptible 
animals. For PHS152-PHS001, the largest difference between resistant and susceptible 
haplotypes was 182-155 (19.5 v.s. 30.3%) which approaches significance (P=0.082). Thus, 
the use of two VNTRs did not allow us to identify haplotypes related to ascites in this 
region. Analysis with additional markers or for more DNA samples could provide 
significance for this region on Gga9.
     The region on Gga1 between 0.5 Mbp and 2.1 Mbp was interrogated with PHS150 and 
PHS135. PHS150 amplified 3 alleles between 175-195 bp. The 175 allele was a rare allele 
present only in the resistant sub-population. The 195 bp allele was the major allele at 
80.72% of the population. The 179 bp allele was present at 18% and was also equally 
represented in the resistant and susceptible sub-populations. All genotypes were 
represented equally between the sub-populations. PHS135 amplified 4 alleles between 
220-256 bp. The 228 and 224 bp alleles were the most frequent with the 228 allele being 
24
slightly over-represented in the susceptible sub-population. The 256, 224, and 220 bp 
alleles were all represented at equal frequencies in both populations. There were no 
genotypes that showed a significant difference between the resistant and susceptible sub-
populations. Unambiguous haplotypes could be assigned for 73 resistant and 89 susceptible 
individuals. No haplotypes showed any significant difference between resistant and 
susceptible sub-populations. 
     The region on Gga1 from 18.38-21.48 Mbp was evaluated with PHS118 and PHS126. 
PHS118 amplified 6 alleles with the 242 bp allele being the most prevalent (33%).  The 
262 bp allele was present only in the resistant sub-population. Genotypic analysis showed 
the 274/242 heterozygote approached significant over-representation in the susceptible sub-
population (6.7 vs. 15.2%, P=0.06) and the 246/246 and 242/242 homozygotes were over-
represented in the resistant sub-populations (P<0.03, 0.04, respectively). PHS126 had no 
significant deviation in allele frequency between the sub-populations, but did have an over-
representation of the 259/244 heterozygote in the susceptible sub-population (4.5 vs. 14%, 
P<0.05). We combined the markers for haplotype analysis for 52 resistant and 52 
susceptible animals. The 242-244 haplotype was significantly over-represented in the 
susceptible sub-population (13.5 vs. 2.9%, P<0.02). We are therefore able to assign a 
haplotype in this region associated with susceptibility to ascites. 
     The region on Gga1 from 127.01 to 128.31 Mbp was interrogated with PHS144 which 
amplified 9 alleles from 248 to 323 bp with similar frequencies for the resistant and 
susceptible sub-populations (Table 2). The 303/263, 263/263, and 303/283 genotypes were 
over-represented in the susceptible sub-population (P<0.015, 0.00005, 0.05, respectively) 
(Table 3). The 288/283 heterozygote was over-represented in both sub-populations 
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compared to the expected counts (P<0.02). The 323/283 heterozygote was under-
represented in both sub-populations with respect to expected frequencies (P<0.028).
     The region on Gga27 between 1.4-3.1 Mbp was interrogated with two primer pairs, 
PHS051 and PHS094. PHS051 amplified two alleles of 145 and 151 bp with no significant 
deviation in either allele or genotype frequencies although the heterozygote 151/145 
approached significance (P=0.0847) (Table 2). PHS094 amplified three alleles between 
180-192 bp at expected frequencies. The 186/186 homozygote was over-represented in the 
susceptible sub-population (20 v.s. 13%; P<.007) as was the 192/192 homozygote (7 v.s. 
3%; P<.054) (Table 3). The 186/180 heterozygote was over-represented in both the 
resistant and susceptible sub-populations but was significantly more frequent in the 
resistant sub-population (56 v.s. 43%; P<0.000001). The 180/180 heterozygote was under-
represented in both sub-populations (P≤0.002). Because of the low diversity at both loci, 
we combined the markers for haplotype analysis. We could unambiguously assign 
haplotypes for 92 individuals (49 resistant, 43 susceptible) (Table 4). The PHS051-PHS094 
haplotype 151-192 was nearly 3x more frequent in the susceptible when compared to the 
resistant population (15.1 v.s. 5.1%, P<0.04).  
     The region on GgaZ from 47.12 to 48.98 Mbp was evaluated with PHS091 which 
amplified 3 alleles from 275 to 295 bp (Table 2). The 295 and 282 bp alleles represented 
over 95% of the population. The female chicken is heterogametic and so hemizygous for 
GgaZ (Table 3). The 282 allele is significantly over-represented in the female susceptible 
sub-population as compared to the resistant (9 v.s. 91%, p<0.03). We were unable to 
develop another polymorphic marker in this region. Therefore, no haplotype analysis could 
be performed.
26
DISCUSSION
     VNTR analysis of the 7 regions identified by the whole genome SNP analysis identified 
5 regions of significant association with respect to ascites/PHS in the chicken at the allele, 
genotype, and/or haplotype level of analysis. Low numbers of alleles and/or low allele 
diversity at many of our VNTR loci and the low numbers of some genotypes required that 
we genotype for more than one VNTR per region. Combining genotypes into haplotypes 
proved informative for some of these regions. There is a notable absence of single allele 
markers for ascites in the chicken which is expected in light of the complex pathology of 
the disease and the involvement of many QTLs. None of our VNTR markers has the power 
to detect significant association with susceptibility at all levels of analysis. PHS009, 
PHS010, PHS150, and PHS118 were significant at either the allele or genotype level when 
used for analysis independently but were far more informative when combined into 
respective haplotypes. There were statistically significant but rare genotypes for PHS144. 
Therefore, the use of any of our VNTR markers alone proved insufficient for informative 
analysis of our populations. Our results demonstrate that multiple VNTRs can be required 
to discern QTL regions. Indeed, the analysis of the 15 Mbp region of Gga9 with PHS001 
and PHS152 only approaches significance.  However, we believe this region is involved in 
ascites/PHS due to the presence of a gene for a serotonin receptor, 5HT2B. Serotonin is a 
key mediator of susceptibility to ascites/PHS based on i.v. microparticle injection method 
(Wideman 2006). Over-expression of 5HT2B has been shown to lead to hypertrophic 
cardiomyopathy in mice. In humans, high levels of serotonin and increased uptake of 
serotonin in vascular tissue of patients with active PAH implicate serotonin transporters as 
contributors to vascular remodeling and hypertrophy (Eddahibi, 2001, MacLean 2009). A 
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polymorphism in the 5’ translated region of the human serotonin receptor 5HT2B has been 
shown to result in increased expression and appears to be linked to an increase in 
hypoxemia, structural lung changes, inflammation, and a decrease in compensatory 
response to pulmonary challenge (Bianchi 2005 and Eddahibi 2003). The presence of 
genotypic evidence associating this region to resistance or susceptibility to ascites and the 
haplotype data that approaches significance warrants further investigation of this region. 
     The region investigated on GgaZ while insufficient for sub-population analysis at this 
time, remains of interest in that females appear to be physiologically and anatomically 
predisposed to early development of ascites symptoms (N. Anthony, unpublished results). 
This information, combined with our preliminary evidence of a significant allele at this 
locus, will drive future investigation of GgaZ.
     The regions on Gga9:13, Gga27:2, and Gga1:20, contain genes related to the 
angiotensin signaling pathway. On Gga9, PHS009, PHS010, and PHS015 are 40KB 
upstream of AGTR1, an Angiotensin II type 1 receptor. In humans, a SNP in the 3’-UTR of 
AGTR1 disrupts a miR155 target site.  This SNP is associated with early onset of PAH in 
humans (Chung 2009 and Martin 2006). The chicken gene for angiotensin-converting 
enzyme (ACE) is on Gga27 at 2.58 Mbp.  Polymorphisms of ACE are associated with 
development of severe IPAH in humans (Abraham 2003).  MAPK11, on Gga1 at 21.81 
Mbp, also known as p38MAPK, is implicated as a downstream effector of inflammatory 
pathways from AGTR1/angiotensin II activation. There is evidence that cross talk between 
p38MAPK and c-Jun N-terminal kinases leads to myocardial cell growth and hypertrophy 
through the integrin-FAK-Src-Ras pathway (Clerk 2006). Additionally, p38MAPK induces 
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iNOS production, a known vasoactive chemical messenger (Mehta 2007, LaPointe 1998; 
Aikawa 2001, Clerk 2006). 
     In summary, we have shown 4 regions on three chromosomes in the chicken that are 
linked to the development of PHS/ascites. The role of serotonin and serotonin receptors in 
pulmonary disease is well established and well characterized pharmacologically and 
histologically. We provide genetic evidence that the serotonin transporter 5HT2B is 
involved in the pathology of PHS/ascites in the chicken. The emerging model for 
angiotensin II receptor 1 as a polymorphic biomarker in humans for early onset IPAH is 
supported by our finding that the regions containing the angiotensin receptor AGTR1 and 
the angiotensin-converting enzyme ACE are linked to the development of PHS/ascites in 
the chicken. Our evidence suggests that the chicken could provide an excellent model for 
human PAH research on disease development and analysis of the underlying genetics of 
PAH.  In addition, identification of these regions as contributing to ascites susceptibility 
will provide biomarkers for use in the poultry industry for selection strategies to reduce the 
incidence of ascites. 
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Primer 
Name Locus Sequence (5'-3') VNTR # Cycles
Annealing 
Temperature # Alleles
Size 
Range 
(bp)
PHS150 Gga1:0.895 ATCTGTAACCAGAGCACATA (AAAC)8 43 43 3 175-195
CTTTTAGGACTTCCTTCTTG
PHS135 Gga1:0.991 CCCCAAGAGGACTCAAAGAAACA (TCCA)9 43 55 4 220-256
AACCGCAATGAACAGGGACACC
PHS118 Gga1:20.28 TGCTCAATCTAGTGGGTGATTT (CTTT)32 43 50 6 242-274
CCCAAGAAGTGGTGGAAAAG
PHS126 Gga1:20.56 TCACGTGGGGAATTAACACA (GGATA)20 45 50 4 239-259
AAGATGGAGTTCCCAAGCAG
PHS144 Gga1:127.85 CCGCTCCCTGTTTATCCTTA (TTCTC)20 45 50 9 248-323
TCCATTTATTGGGGAGTGAAA
PHS015 Gga9:13.111 TTTTTCTTGTGTATATGGCTAAT (GA)13 43 45 3 151-167
GCAATGCAAAAATGTGAAA
PHS009 Gga9:13.42 ATTGTTCATAGCACTTCATTTCT (GA)13 40 52 3 267-277
AGCAGTCATAAGCCTACATTTTG
PHS010 Gga9:13.54 ACAGAATTAGGGTGGGTTTTTG (AC)16 43 50 2 161,151
GCGGTGTGCCTGCTTTCT
PHS152 Gga9:15.882 GTGACATTCATACTGGAAAC (AAAG)12 45 43 2 198,182
GCTATCTTGTTTGCTAATCT
PHS001 Gga9:15.96 GAGGCTCCATCGCTATTGA (CA)17 43 50 5 139-157
AGTTTTTGTCTTCCCAGTCTCC
PHS051 Gga27:2.285 CATCCCTGAGCCCACCCCAACTG (CA)25 43 60 2 145,151
CCACGTGCCCGGAGGAGGAAATAA
PHS094 Gga27:2.860 GAACACAGTGAGGCACGAGA (CA)17 43 45 3 180-192
GTGTGCTGTGCTCTGATGCT
PHS091 GgaZ:48.61 TGCATACAAGCTCATACAAATCTG (GAAA)25 43 50 3 270-295
AAAAATCCACTTCCCAAATCTCT
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Table 1. All PHS project primer pairs listed with location, sequence (Forward over 
Reverse), VNTR, number of PCR cycles, optimized annealing temperature (°C), number of 
alleles amplified, and the size range of those alleles (bp).
Primer Allele (bp)
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value Primer Allele (bp)
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value
PHS015 167 17(16) 16(17) 0.730 PHS126 259 24(27) 42(39) 0.230
161 101(104) 113(110) 0.699 249 75(72) 103(106) 0.640
151 62(60) 62(64) 0.741 244 36(34) 47(49) 0.099
PHS009 277 88(94) 111(105) 0.374 239 1(3) 6(4) 0.822
275* 63(53) 49(59) 0.055 PHS051 151 59(61) 53(51) 0.681
267 29(33) 40(36) 0.374 145 83(81) 65(67) 0.720
PHS010 161 142(137) 147(152) 0.581 PHS094 192 28(33) 42(37) 0.189
151 30(35) 43(38) 0.272 186 89(91) 102(100) 0.729
PHS152 198 85(79) 82(88) 0.375 180 61(53) 50(58) 0.134
182 93(99) 115(109) 0.426 PHS144 323 9(7) 5(7) 0.207
PHS001 157 10(12) 14(12) 0.510 313 11(12) 15(14) 0.599
155 60(66) 76(70) 0.319 303 29(32) 38(35) 0.494
153 13(16) 20(17) 0.301 293 20(20) 22(22) 0.983
147 54(50) 50(54) 0.471 288 11(15) 20(16) 0.182
139 43(36) 32(39) 0.121 283 30(24) 21(27) 0.104
PHS135 256 3(2) 2(3) 0.571 278 28(26) 26(28) 0.518
228 104(111) 130(123) 0.375 263 26(29) 36(33) 0.384
224 64(71) 64(71) 0.627 248 4(3) 3(4) 0.608
220 2(2) 2(2) 0.256 Female Female 
PHS150 195 134(134) 154(154) 0.972 PHS091 295 18(16) 22(27) 0.295
179 28(30) 36(34) 0.644 *282 1(3) 10(5) 0.016
*175 4(2) 0(2) 0.032 275 0(0) 0(0) 0.534
PHS118 274 40(38) 40(42) 0.637
270 26(26) 28(28) 0.909 Male Male
266 19(20) 24(23) 0.676 295 85(86) 84(81) 0.742
*262 5(2) 0(3) 0.018 282 17(17) 14(16) 0.623
246 34(34) 37(37) 0.930 275 2(1) 0(1) 0.106
242 56(60) 71(67) 0.460
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Table 2. Allele count for Resistant (Res) vs Susceptible (Sus) birds for each 
locus  where observed (Obs) versus expected (Exp)  significantly deviated 
(P=0.055) are indicated (*).
Locus Genotype
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value
PHS010 151/151 4(3) 8(4) 0.033
PHS152 198/198 16(18) 17(19) 0.039
PHS001 155/155 11(12) 20(13) 0.043
147/139 19(10) 10(11) 0.005
PHS118 266/262 2(0) 0(0) 0.001
246/246 7(3) 5(3) 0.020
242/242 17(10) 12/11 0.027
PHS094 192/192 3(3) 7(3) 0.054
186/186 12(23) 19(26) 0.007
186/180 50(27) 42(30) 0.000
180/180 2(8) 1(9) 0.001
PHS144 263/263 3(2) 11(3) 0.000
303/283 3(5) 8(4) 0.042
288/283 5(2) 4(2) 0.014
PHS135 224/220 0(1) 2(1) 0.041
PHS091 (Female) 282 1(3) 10(5) 0.016
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Table 3. Genotypes in the Resistant (Res) and Susceptible 
birds (Sus) where observed (Obs) versus expected (Exp) 
significantly deviated (represented >1% of the total population 
and P≤0.055).
Haplotype %Resistant %Susceptible P-value Haplotype %Resistant%Susceptible P-value
PHS015+PHS009 PHS118+126
151-277 9.2 13.1 0.390 242-239 1.0 1.0 1.000
167-277 3.1 1.6 0.487 *242-244 2.9 13.5 0.008
161-275 42.9 48.4 0.549 242-249 21.2 16.3 0.423
167-275 2.0 0.0 0.115 242-259 15.4 8.7 0.162
161-275 11.2 7.4 0.347 246-244 2.9 1.9 0.655
151-275 18.4 12.3 0.248 246-249 14.4 14.4 1.000
151-267 1.0 4.1 0.169 246-259 1.9 1.9 1.000
167-267 0.0 2.5 0.121 266-244 2.9 4.8 0.480
161-267 12.2 10.7 0.728 266-249 5.8 8.7 0.439
PHS009+PHS010 266-249 1.0 0.0 0.317
277-161 47.1 52.0 0.555 266-259 0.0 1.0 0.317
277-151 2.9 7.9 0.075 266-259 1.0 0.0 0.317
*275-161 38.2 23.7 0.026 270-244 1.0 1.9 0.564
275-151 2.2 3.3 0.582 270-249 2.9 7.7 0.132
267-161 3.7 7.9 0.141 270-259 1.9 0.0 0.157
267-151 5.9 5.3 0.824 274-239 0.0 1.9 0.157
PHS051+094 274-244 4.8 2.9 0.480
*151-192 5.1 15.1 0.030 274-249 17.3 12.5 0.369
145-186 30.6 33.7 0.710 274-259 1.9 1.0 0.564
151-186 21.4 22.1 0.923
145-192 12.2 10.5 0.721
151-180 12.2 7.0 0.254 PHS152+PHS001
145-180 18.4 11.6 0.242 182-139 10.9 8.3 0.498
PHS150+PHS135 182-147 14.8 15.2 0.949
195-228 50.7 55.1 0.591 182-153 4.7 6.1 0.633
195-224 32.9 28.1 0.436 182-155 19.5 30.3 0.082
179-256 0.7 0.6 0.888 182-157 3.1 5.3 0.393
179-228 11.6 12.4 0.853 198-139 10.2 6.1 0.245
179-224 2.1 3.4 0.479 198-147 14.1 11.4 0.541
179-220 0.7 0.6 0.888 198-153 3.9 2.3 0.453
175-228 0.7 0.0 0.270 198-155 18.0 13.6 0.379
175-224 0.7 0.0 0.270 198-157 0.8 1.5 0.582
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Table 4. Percentages for haplotypes where two or more VNTR markers could be 
combined (P≤0.05). The percentage of the sub-populations possessing a haplotype (% 
Resistant or % Susceptible) was compared using a Chi test (P-value).
Chapter 3: Genetic Analysis of Chromosomal Regions Associated with Ascites in the 
Chicken: Candidate Genes
     In 2006, a genome wide SNP analysis of chickens was conducted by a consortium of 
researchers that analyzed SNPs at approximately 10KB spacing for a total of 2733 SNPs of 
which 1763 were informative (Cheng 2006). The association of SNPs with right ventricle/
whole ventricle weight and resistance or susceptibility to ascites was evaluated in the 
population of birds. From those results, we identified 7 chromosomal regions on 4 
chromosomes (Figure 1) that were associated with right ventricle/whole ventricle weight 
and ascites and designed primers to amplify proximal VNTR (Table 1). We used these 
markers to evaluate 2 sub-populations (resistant and susceptible to PAH) from a susceptible 
line of chickens. We found loci significantly associated with PAH at an allele, genotype, or 
haplotype level of analysis. We subsequently interrogated the regions identified by our 
markers for genes that could be relevant to ascites and PAH.
     We analyzed our data in a hierarchal order from allele to genotype to combined 
haplotype level.  At the allele level, we found several loci that showed significant 
association to susceptibility to PAH. However, the majority of our VNTR markers 
displayed low allele diversity, typically having 3-5 alleles with 2 major alleles and other 
alleles present at very low frequency. We subsequently combined alleles for genotypes and 
analyzed the sub-populations for genotype and probable haplotype. We found several 
genotypes at multiple loci that appear to be associated with resistance and susceptibility to 
PAH (Tables 2-8). The genotype analysis yielded adequate results for breeding 
experiments to commence, but the combination of genotypes into probable haplotypes 
proved much more informative (Tables 9-13).
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     A review of the genes located within the regions we have demonstrated to be associated 
with PAH in the chicken identified 10 candidate genes for possibly mediating the QTL 
effects.
     When we combined genotypes for 3 markers between 13.1-13.5 Mbp, we identified 2 
haplotypes significantly associated with either resistance or susceptibility to ascites. These 
haplotypes combined represent 36% of the total population for which haplotypes could be 
assigned. This locus, 13.1-13.9 Mbp, contains the gene for angiotensin II type 1 receptor 
(AGTR1). Based on current models for angiotensin’s role in vascular tension, we are 
confident that this gene is an excellent candidate for sequence analysis to identify 
polymorphisms associated with variation in pulmonary response between our resistant and 
susceptible sub-populations. Angiotensin II-type receptor 1(AGTR1) is located at 13.49 
Mbp on chromosome 9 in the chicken (Gga9). Recently published work indicates that a 
polymorphism in the 3’-untranslated region in the AGTR1 gene in humans is associated 
with early onset IPAH (Chung 2009). This 3’ UTR SNP may alter the target sequence for a 
miRNA which would imply a dysregulation of AGTR1 expression. The vasoconstrictor 
angiotensin is regulated in humans by angiotensin-converting enzyme (ACE) which is 
required to cleave the precursor angiotensinogen into angiotensins I and II. The chicken 
ACE homolog is found on Chromosome 27 at 2.58Mbp. Only angiotensin II is known to be 
biologically active (Chung 2009, Campbell 1987).  Activation of AGTR1 mediates an up-
regulation of a mitogen-activated protein kinase/extracellular signal-regulated kinase 
(ERK) pathway in vascular smooth muscle cells that is highly indicated in ventricular 
hypertrophy (Kagiyama 2002). Furthermore, when we combined two markers at the locus 
on Gga27 at 2.2-2.9 Mbp, we found a significant haplotype associated with susceptibility to 
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PAH. The gene for angiotensin converting enzyme (ACE) is located at Gga27:2.58 Mbp in 
the chicken. This gene is responsible for converting angiotensinogen into biologically 
active angiotensin II. The relative interaction between these two loci, one on Gga9 and one 
on Gga27 is an obvious nod to the angiotensin biochemical pathway in vascular response to 
pressure changes, and one that has clear implications in PAH.
     Integrin beta-3 (ITGB3) is located on Gga27 at 2.2Mbp. Thrombocytes are involved in 
the serotonin response to elevated pulmonary arterial pressure. Integrins are necessary for 
platelets (the thrombocyte homolog) to bind fibrinogen and function properly (Di 
Castelnuovo 2005). Therefore the ITGB3 gene remains on the list of candidate genes for 
PAH. 
     HRAS is located on Gga9 of the chicken at 14.25Mbp. Ras is a well established GTPase 
switch that is activated by myriad extracellular stimuli and consequently activates the Raf-
MEK-ERK kinase pathway (Shields 2000). The activation of Ras and its subsequent 
downstream effects are still not well characterized, but its role as an activator of 
intracellular pathways is well known. The activation of the ERK pathway and subsequent 
MAPKs and the possible implications where inflammation and tissue proliferation are 
concerned should not be ignored in light of the important role that inflammation, the 
immune system, and MAP kinases play in the response to respiratory demands put on 
chickens in pulmonary challenge, and potentially, in humans living with IPAH.
     Costello syndrome, a rare condition that is hallmarked by cardiac hypertrophy and other 
abnormalities, was addressed by a consortium of investigators in 2005 with the intention of 
finding genotypic evidence of genes linked to the particular symptoms or phenotypes of the 
syndrome (Gripp 2005). Their results found that germ line HRAS mutations lead to 
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Costello syndrome in most patients. Ras serves as a highly regulated GTPase switch that 
can be turned on by a highly varied number of signals. Costello syndrome and IPAH/PHS 
are highly related in physiological implications, and the validated involvement of HRAS 
mutations represents an ideal candidate gene possibility for further investigation.
     The third locus that yielded significant haplotype association with PAH was located on 
Gga1:20.2-22.5 Mbp. This locus yielded one haplotype significantly associated with 
susceptibility which was present in 13% of the susceptible sub-population. One megabase 
upstream of the two markers combined for haplotype is the gene for mitogen activated 
protein kinase 11 (MAPK11), also known as p38MAPK. p38MAPK has been used as a 
target for pharmacological intervention in hypertension patients for some time, and has 
been implicated for involvement in hypertension in rats possessing divergent expression 
levels in hypertensive versus normotensive animals (Ravingerova 2003, Buermans 2005).
     MAPK11, also known as p38MAPK, is located on Gga1 at 21.8 Mbp. p38MAPK is 
implicated as a downstream effector from AGTR1/angiotensin II activation that leads to 
myocardial cell growth and hypertrophy through the integrin-FAK-Src-Ras pathway 
(Mehta 2007, LaPointe 1998). The primary target of p38MAPK activation if 
MAPKMAPK-2, which is a protein kinase that subsequently activates a heat shock protein, 
promoting polymerization of actin filaments (Ranvingerova 2003). p38MAPK has been 
indicated as a target of many inflammatory stimuli indicating an essential role in cell 
inflammatory responses (Raingeaud 1995, Han 1997). Importantly, p38MAPK has also 
been shown to regulate iNOS expression at the transcriptional level (Da Silva 1997). These 
various levels of vasoactive regulation that have been shown to be dependent upon 
p38MAPK implicate it as a candidate gene for involvement in the progression of PAH.
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      There was a fourth region that approached significance when analyzed for haplotype. 
This region is at 15.8 Mbp on Gga9 and is directly downstream from the gene for serotonin 
receptor 2B (5HT2B). The combination of PHS152 and PHS001 provide a haplotype that is 
associated with susceptibility and present in 30% of the susceptible sub-population. We are 
currently developing more markers for this region due to the very clear involvement of 
serotonin in the response to PAH. Serotonin is a well characterized vasoconstrictor with an 
established role in pathologies of the cardiopulmonary system in both chickens and 
humans.
     Serotonin receptor 5HT2B is located at 16.2Mbp on Gga9. Serotonin (5HT) is arguably 
the most potent vasoconstrictor known in poultry and is actively carried by thrombocytes 
which are the avian equivalent to human platelets (Kunicki 1985, Chapman  2002). If 
administered intravenously, 5HT is capable of causing extensive pulmonary arterial 
constriction leading to suffocation if careful administration isn’t observed. A study of 
IPAH and FPAH patients and serotonin transporter [5HT2B] divergent alleles found a 
correlation between age of diagnosis of PAH and a polymorphism in 5HT2B (Willers 
2005). In a related study, it was found that the presence of any amine transporter in 
combination with serotonin-specific receptors was sufficient to induce hypertrophy 
independently of serotonin concentrations (Bianchi 2005). While either mechanism, 
receptor independent or dependent can lead to hypertrophy, there is a cumulative effect 
noted with an abundance of both amine transporters and 5HT2B receptor leading to 
perceptibly greater hypertrophy. In short, much weight is placed upon the serotonin 
transporter in PAH development, with less emphasis put upon the plasma serotonin 
concentrations when determining susceptibility to PAH. The presence of both 5HT and 
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5HT2B leads to the downstream activation of mitogen activated protein kinase (MAPK) 
driving the transcription of genes highly implicated in cell proliferation (Machado 2006). 
Serotonin has also been shown to interact synergistically with Urotensin II leading to the 
induction of proliferation via a G-protein coupled receptor/MAPK pathway leading to 
vascular remodeling (Watanabe 2001). 
     Somatostatin (SST) is located on Gga9 at 15.9Mbp. Somatostatin is a pleiotropic 
chemical signal that acts through a set of 6 G-protein coupled receptors known as SSTR1-
SSTR5 to carry out many biological functions that may be summarized under two basic 
functions: inhibition of secretion or inhibition of proliferation. In some secreting cells, 
somatostatin is released by increasing cytosolic Ca2+ concentration and/or membrane 
depolarization. In a feedback loop, SST serves as an inhibitor of cAMP and Ca2+ release 
upon ligand binding. Free Ca2+ has been shown to be elevated in hypertensive rats and 
humans (Bruschi 1985, Zhang 2005). Somatostatin is also indicated in the inhibition of 
proliferation in several cell types by MAPK path regulation. SST release can also be 
stimulated by a variety of cytokines, growth factors, corticotrophin-releasing hormone and 
the inflammatory cytokines IL-1, TNFα, and IL-6 (Bronstein-Sitton 2006). Immunological 
response to respiratory challenge could indicate that the signal by inflammatory cytokines 
to release somatostatin is an important upstream regulator of PAH. Inhibition of MAPK 
signaled smooth muscle proliferation ties SST directly into PAH pathogenesis. 
     Fibroblast growth factor-12 (FGF12) is located on Gga9 at 14.52Mbp. It has been 
established that inhibition of FGF by FGF-specific antibody can inhibit the proliferation of 
smooth muscle cell after vascular injury and that nitric oxide (NO), in a primary response 
to vascular injury, amplifies the FGF stimulated proliferation of smooth muscle cells 
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(Lindner 1991, Janssens 1998). Nitric oxide is thought to be one of the most important 
chemical messengers and vasodilators involved in pulmonary hypertension syndrome in 
chickens. It is involved in many processes ranging from cardiovascular to immune in 
nature and has been established as a potential human QTL in echocardiographic 
[hypertensive] phenotypes (Kraja 2008). NO is synthesized by a breakdown of l-arginine in 
an enzymatic process carried out by an inducible nitric oxide synthase (iNOS) or a 
constitutive endothelial nitric oxide synthase (eNOS) (Wideman 2006). iNOS binds Ca2+/
Calmodulin to produce massive amounts of nitric oxide, a common chemical response to 
pulmonary occlusion or elevated pulmonary pressure (Wideman et al 2004). Taken 
together, these facts support a nitric oxide mediated response to vascular challenge that 
results in an effect upon the various growth factors, including FGF12, in the vascular 
system. Fibroblast Growth Factor 12 is a well established growth factor responsible for the 
induction of granulation tissues and concordant fibrosis, collagen production, and 
angiogenesis (Roberts 1986). The pathobiology of PAH requires the involvement of growth 
factors and angiogenesis appears to be a consistent response to occlusion of the pulmonary 
vasculature as an effort to bypass the blockage. It is therefore logical that FGF12 could 
play a role as a QTL and serve as a marker for genetic selection for breeding purposes.
     When we combined the genotypes for PHA150 and PHS135, located between 0.895 and 
0.991 Mbp on Gga1, we got no significant association with PAH. However, the addition of 
markers in this region may show an association not clearly defined with only two primer 
pairs. In this region are two potential candidate genes; calmodulin-3 (CALM-3) and 
neuroendothelial transforming gene (NET1).
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     Calmodulin-3 (CALM-3) is located on Gga1 at 1.0Mbp and may be highly implicated in 
the nitric oxide synthesis pathway. Two variations on the theme of nitric oxide synthesis 
may play a role in the response of the pulmonary vascular system to respiratory challenge 
or pressure changes. There are currently two accepted forms of nitric oxide synthase, eNOS 
(the constitutively expressed endothelial nitric oxide synthase) and the macrophage carried 
inducible iNOS. eNOS binds Ca2+ in a readily reversible way and so exhibits a more 
transient activation whereas iNOS binds Ca2+/Calmodulin tightly even at very low Ca2+ 
concentrations (Korhonen 2005). iNOS is highly regulated by a calcium/calmodulin-
dependent protein kinase II in vascular smooth muscle; based on the role that iNOS plays 
in PAH and as the highly important upstream regulator of chemical signals for nitric oxide, 
it is reasonable to include CALM-3 on the list of potential candidate genes involved in 
PAH. 
     Neuroendothelial transforming gene-1 (Net1) is located on Gga1 at 1.01Mbp. NET1 is a 
guanine exchange factor for the small G protein RhoA. RhoA is recognized as a major 
regulator of arterial tone, smooth muscle contraction and proliferation, and actin stress fiber 
formation (Sauzeau 2001). Rho family proteins are key regulators of cytoskeletal 
organization and are often involved in oncogenic transformation; importantly, the Rho 
GTPases comprise a main branch of the Ras superfamily of biomolecular switches 
involved in the activation of many downstream effectors including relative vasoactive 
substances such as urotensin and somatostatin. Translocation of NET1 to the cytoplasm of 
a cell results in the formation of actin stress fibers and cellular transformation (Qin 2005). 
NET-1 has also been shown to be an important oncogene and guanine exchange factor 
(GEF) involved in the activation of RhoA leading to increased proliferation, 
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reorganization, and migration of epithelial cells (Qin 2005, Murray 2008). The increased 
expression of NET-1 therefore may be involved in the increase of active RhoA. Increased 
activity of other biomolecular switches like Rho GTPases would actively propagate signals 
by interacting with downstream effector proteins. A hallmark of all forms of PAH 
remodeling is the distal extension of smooth muscle into small peripheral arteries (Humbert 
2004) which could involve NET 1 and RhoA cytoskeleton remodeling.
     GgaZ was interrogated for a single VNTR. PHS091 was used to analyze the resistant 
and susceptible sub-populations. The female chicken is heterogametic and possesses only 
one copy of the Z chromosome. As such, we identified a hemizygous genotype in the 
female sub-population associated with susceptibility to ascites. Further investigation with 
additional markers may identify ascites as a sex-linked disease. There are currently no 
candidate genes for ascites on GgaZ.
     The region Gga1:127 Mbp was interrogated with PHS144. This primer pair was 
polymorphic but non-significant when analyzed for association with susceptibility or 
resistance to ascites. The gene for a Rho-GTPase is very proximal to our PHS144 and with 
additional markers, may be considered as a candidate gene for PAH/ascites.
     Studies to characterize genes involved in hypertension in humans have yielded complex 
gene systems, thought to be a result of redundant biochemical pathways contributing to the 
regulation of blood pressure (Bull 2007). These studies can be resolved when complex 
interaction between the renin-angiotensin system, nitric oxide dependent and independent 
regulation of the vascular system, and sodium balance systems are considered. Quantitative 
traits often have redundant biochemical pathways contributing to an overall characteristic. 
In the case of PAH, multiple pathways for the regulation of vascular tone and response to 
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pulmonary challenge exist and interact with one another. In this work, we find four 
potential candidate genes for involvement with PAH, all directly involved in vasotension 
regulation and/or hypertrophy of cardiac tissue.  
     After evaluating each locus independently and with respect to proximal markers, we 
find AGTR1, ACE, 5HT2B, and p38MAPK are attractive candidates as QTL for 
PAH/ascites. All of these genes have been investigated in human medicine. AGTR1 and 
5HT2B have polymorphism studies linking age of diagnosis of PAH and a divergent 
genotype profile (Chung 2009, Willers 2005). Functional polymorphisms somewhere 
between intron 18 and the 3’UTR as well as one in the 5’UTR have been indicated as 
potentially interacting with other risk factors for PAH (Sayed-Tabatabaei 2006). 
p38MAPK has been well studied as a potential therapeutic target for PAH patients (Shirai 
2007, MacLean 2009). 
      Our work is very easily applicable to agriculture where marker-assisted selection of 
breeding stocks is an attractive prospect in light of the economical impact of the ability to 
impose selection upon animals before expending resources rearing them. In human 
medicine, biomarkers for PAH may lead to better characterization of the biochemical 
pathways involved in the disease, potentially point the way for pharmaceutical 
intervention, and provide earlier detection through genetic screens. Our identification of 
significantly associated genes already implicated in human IPAH in a population of ascites/
PAH-susceptible chickens provides evidence that the chicken is an excellent animal model 
for IPAH research. The application of VNTR genetic mapping may pave the way for a 
better chicken as both food and medical model.
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Figure 1. Schematic representation of chicken chromosomes (Gga9, 1, 27, and Z) with 
VNTR primer pairs (↑) and candidate genes (↔) noted at approximate locations (Mbp). 
Primer 
Name Locus Sequence (5'-3') VNTR # Cycles
Annealing 
Temperature # Alleles
Size 
Range 
(bp)
PHS150 Gga1:0.895 ATCTGTAACCAGAGCACATA (AAAC)8 43 43 3 175-195
CTTTTAGGACTTCCTTCTTG
PHS135 Gga1:0.991 CCCCAAGAGGACTCAAAGAAACA (TCCA)9 43 55 4 220-256
AACCGCAATGAACAGGGACACC
PHS118 Gga1:20.28 TGCTCAATCTAGTGGGTGATTT (CTTT)32 43 50 6 242-274
CCCAAGAAGTGGTGGAAAAG
PHS126 Gga1:20.56 TCACGTGGGGAATTAACACA (GGATA)20 45 50 4 239-259
AAGATGGAGTTCCCAAGCAG
PHS144 Gga1:127.85 CCGCTCCCTGTTTATCCTTA (TTCTC)20 45 50 9 248-323
TCCATTTATTGGGGAGTGAAA
PHS015 Gga9:13.111 TTTTTCTTGTGTATATGGCTAAT (GA)13 43 45 3 151-167
GCAATGCAAAAATGTGAAA
PHS009 Gga9:13.42 ATTGTTCATAGCACTTCATTTCT (GA)13 40 52 3 267-277
AGCAGTCATAAGCCTACATTTTG
PHS010 Gga9:13.54 ACAGAATTAGGGTGGGTTTTTG (AC)16 43 50 2 161,151
GCGGTGTGCCTGCTTTCT
PHS152 Gga9:15.882 GTGACATTCATACTGGAAAC (AAAG)12 45 43 2 198,182
GCTATCTTGTTTGCTAATCT
PHS001 Gga9:15.96 GAGGCTCCATCGCTATTGA (CA)17 43 50 5 139-157
AGTTTTTGTCTTCCCAGTCTCC
PHS051 Gga27:2.285 CATCCCTGAGCCCACCCCAACTG (CA)25 43 60 2 145,151
CCACGTGCCCGGAGGAGGAAATAA
PHS094 Gga27:2.860 GAACACAGTGAGGCACGAGA (CA)17 43 45 3 180-192
GTGTGCTGTGCTCTGATGCT
PHS091 GgaZ:48.61 TGCATACAAGCTCATACAAATCTG (GAAA)25 43 50 3 270-295
AAAAATCCACTTCCCAAATCTCT
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Table 1. All PHS project primer pairs listed with location, sequence (Forward over 
Reverse), VNTR, number of PCR cycles, optimized annealing temperature (°C), number 
of alleles amplified, and the size range of those alleles (bp).
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Primer Locus Allele(bp)
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value Genotypes
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value
PHS150 Gga1:0.895 195 134(134) 154(154) 0.972 195/195 56(54) 65(62) 0.671
179 28(30) 36(34) 0.644 195/179 20(24) 24(28) 0.276
175* 4(2) 0(2) 0.032 195/175 2(2) 0(2) 0.170
179/179 4(2) 6(3) 0.064
PHS135 Gga1:0.991 256 3(2) 2(3) 0.571 228/228 31(35) 47(38) 0.129
228 104(111) 130(123) 0.375 224/220* 0(1) 2(1) 0.041
224 64(71) 64(71) 0.256 256/224 1(1) 1(1) 0.864
220 2(2) 2(2) 0.627 228/220 1(1) 0(1) 0.318
156/228 2(2) 1(2) 0.515
224/224 15(11) 13(13) 0.269
228/224 39(40) 35(44) 0.176
Table 2. Combined data for Gga1:0.8 Mbp (Locus) that was interrogated with PHS150 and 
PHS135 (Primer). Allele (bp) counts for resistant (Res) v.s. susceptible (Sus) birds for each 
locus where observed (Obs) versus expected (Exp) significantly deviated (P≤0.055) are 
indicated (*). Genotypes in the resistant (Res) and susceptible (Sus) birds were scored and 
where observed (Obs) versus expected (Exp) significantly deviated (representing >1% of 
the total population and P≤0.055) is noted.
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Primer Locus Allele(bp)
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value Genotypes
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value
PHS118 Gga1:2.028 274 40(38) 40(42) 0.637 274/274 7(4) 5(4) 0.125
270 26(26) 28(28) 0.909 274/270 9(5) 8(6) 0.076
266 19(20) 24(23) 0.676 274/266 5(4) 3(4) 0.389
262* 5(2) 0(3) 0.018 274/262 1(0) 0(0) 0.305
246 34(34) 37(37) 0.930 274/246 5(7) 4(8) 0.117
242 56(60) 71(67) 0.460 274/242 6(13) 15(14) 0.058
270/270 1(2) 1(2) 0.352
270/266 4(3) 4(3) 0.427
270/262 1(0) 0(0) 0.195
270/246 5(5) 4(5) 0.577
270/242 5(9) 10(9) 0.219
266/266 2(1) 2(1) 0.306
266/262* 2(0) 0(0) 0.001
266/246 1(4) 5(4) 0.136
266/242 3(7) 8(7) 0.141
262/262 0(0) 0(0) 0.856
262/246 1(0) 0(0) 0.276
262/242 0(1) 0(0) 0.197
246/246* 7(3) 5(3) 0.020
246/242 8(11) 13(12) 0.326
242/242* 17(10) 12/11 0.027
PHS126 Gga1:20.56 259 24(27) 42(39) 0.244 259/259 1(3) 7(5) 0.092
249 75(72) 103(106) 0.670 249/249 20(19) 28(34) 0.538
244 36(34) 47(49) 0.105 244/244 1(4) 9(7) 0.392
239 1(3) 6(4) 1.000 239/239 0(0) 0(0) 0.799
259/249 12(14) 27(25) 0.137
259/244* 10(7) 8(12) 0.039
259/239 0(0) 1(2) 0.360
249/244 23(18) 36(32) 0.252
249/239 0(2) 5(6) 0.367
244/239 1(1) 0(3) 0.150
Table 3. Allele and genotype data for PHS118 and PHS126 on Gga1. 
Columns and analyses are as indicated in Table 2.
54
Table 4. Allele and genotype data for PHS144 on Gga1:127.85 Mbp. 
Columns and analyses are as indicated in Table 2.
.
Primer Locus Allele(bp)
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value Genotypes
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value
PHS144 Gga1:127.85 323 9(7) 5(7) 0.207 313/313 0(0) 1(1) 0.432
313 11(12) 15(14) 0.599 303/303 3(5) 4(5) 0.093
303 29(32) 38(35) 0.494 293/293 1(2) 1(1) 0.431
293 20(20) 22(22) 0.983 288/288 0(0) 1(4) 0.004
288 11(15) 20(16) 0.182 283/283 3(4) 1(1) 0.409
283 30(24) 21(27 0.104 278/278 2(4) 2(2) 0.272
278 28(26) 26(28) 0.518 263/263* 2(3) 3(11) 0.000
263 26(29) 36(33) 0.384 248/248 0(0) 0(1) 0.000
248 4(3) 3(4) 0.608 323/313 1(1) 0(0) 0.406
323/303 2(3) 1(1) 0.246
323/293 1(1) 1(0) 0.440
323/288 1(0) 1(0) 0.288
323/283* 2(3) 1(2) 0.028
323/278 2(0) 1(1) 0.202
323/263 1(1) 1(1) 0.738
313/303 2(0) 3(3) 0.168
313/293 1(1) 2(4) 0.090
313/288 1(0) 2(0) 0.127
313/283 2(1) 2(1) 0.384
313/278 2(3) 2(3) 0.287
313/263 2(4) 3(2) 0.066
313/248 0(1) 0(0) 0.128
303/293 3(2) 4(6) 0.291
303/288 2(0) 4(2) 0.085
303/283* 5(3) 4(8) 0.042
202/278 5(2) 5(7) 0.138
303/263* 5(6) 7(1) 0.014
303/248 1(3) 1(0) 0.004
293/288 1(3) 2(1) 0.085
293/283 4(2) 2(1) 0.209
293278 3(4) 3(5) 0.247
293/263 3(3) 4(3) 0.540
288/283* 2(5) 2(4) 0.014
288/278 2(2) 3(2) 0.623
288/263 2(1) 4(3) 0.486
283/278 5(6) 3(2) 0.480
283/263* 5(2) 4(1) 0.051
283/248 1(0) 0(0) 0.305
278/263 4(3) 5(2) 0.135
278/248 1(0) 0(0) 0.297
263/248 1(0) 1(1) 0.337
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Primer Locus Allele(bp)
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value Genotypes
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value
PHS015 Gga9:13.111 167 17(16) 16(17) 0.730 167/167 0(1) 1(1) 0.373
161 101(104) 113(110) 0.699 167/161 10(9) 11(10) 0.636
151 62(60) 62(64) 0.741 167/151 7(5) 3(6) 0.186
161/161 26(30) 31(32) 0.466
161/151 39(35) 39(37) 0.408
151/151 8(10) 10(11) 0.500
PHS009 Gga9:13.42 277 88(94) 111(105) 0.374 277/277 22(25) 32(27) 0.304
*275 63(53) 49(59) 0.055 277/275 29(28) 26(31) 0.365
267 29(33) 40(36) 0.374 277/267 15(17) 21(19) 0.494
275/275 13(8) 8(9) 0.062
275/267 8(10) 8(9) 0.212
267/267 3(3) 6(3) 0.137
PHS010 Gga9:13.54 161 142(138) 147(152) 0.580 161/161 59(55) 60(61) 0.570
151 30(35) 43(38) 0.270 151/151 4(4) 8(4) 0.030
161/151* 23(28) 27(31) 0.270
Table 5. Allele and genotype data for PHS015, PHS009, and PHS010 on Gga9:13 
Mbp. Columns and analyses are as indicated in Table 2.
  
 
Primer Locus Allele(bp)
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value Genotypes
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value
PHS051 Gga27:2.285 151 59(61) 53(51) 0.681 151/151 16(13) 15(11) 0.147
145 83(81) 65(67) 0.720 151/145 27(35) 27(29) 0.085
145/145 28(23) 21(19) 0.260
PHS094 Gga27:2.86 192 28(33) 42(37) 0.189 192/192* 3(3) 7(3) 0.054
186 89(91) 102(100) 0.729 192/186 15(17) 22(19) 0.358
180 61(53) 50(58) 0.134 192/180 7(10) 6(11) 0.079
186/186 12(23) 19(26) 0.007
186/180* 50(27) 42(30) 0.000
180/180* 2(8) 1(9) 0.001
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Table 7. Allele and genotype data for PHS051 and PHS094 on Gga27:2. Columns and 
analyses are as indicated in Table 2.
Primer Locus Allele(bp)
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value Genotypes
Res 
Obs(Exp)
Sus 
Obs(Exp) P-value
PHS152 Gga9:15.882 198 85(79) 82(88) 0.375 198/198* 26(18) 17(23) 0.039
182 93(99) 115(109) 0.426 198/182 3(44) 47(43) 0.096
182/182 30(27) 34(30) 0.389
PHS001 Gga9:15.96 157 10(12) 14(12) 0.510 157/157 0(0) 1(0) 0.258
155 60(66) 76(70) 0.319 155/155* 11(12) 20(13) 0.043
153 13(16) 20(17) 0.301 153/153 0(1) 3(1) 0.007
147 54(50) 50(54) 0.471 147/147 4(7) 10(8) 0.144
139 43(36) 32(39) 0.121 139/139 4(4) 1(4) 0.139
157/155 2(4) 4(5) 0.264
157/153 1(1) 3(1) 0.070
157/147 4(3) 2(3) 0.373
157/139 3(2) 3(2) 0.592
155/153 6(6) 4(6) 0.371
155/147 18(18) 17(20) 0.549
155/139 12(13) 11(14) 0.364
153/147 5(4) 1(5) 0.081
153/139 1(3) 6(3) 0.063
147/139* 19(10) 10(11) 0.005
Table 6. Allele and genotype data for PHS152 and PHS001 on Gga9:15 Mbp. Columns 
and analyses are as indicated in Table 2.
.
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Table 8. Allele and genotype data for PHS091 on GgaZ: 48 Mbp. Columns and 
analyses are as indicated in Table 2.
Table 9. Alleles for homozygous individuals 
were combined into probable haplotypes for 
PHS150 and PHS135 at Gga1:0.8 Mbp. The 
counts of observed (Obs) versus expected 
(Exp) haplotypes for the resistant (Res) and 
susceptible (Sus) sub-populations were 
compiled. Haplotypes where significant 
deviation between resistant and susceptible 
sub-populations are noted (*).
 Primer Locus Allele(bp) Female Res. Female Sus. P-value Male Res. Male Sus. P-value
Obs(Exp) Obs(Exp) Obs(Exp) Obs(Exp)
PHS091 GgaZ:48.61 295 28(32) 28(35) 0.171 85(87) 84(82) 0.757
282* 10(8) 14(8) 0.031 17(16) 14(15) 0.709
275* 3(1) 1(1) 0.017 2(1) 0(1) 0.170
270 0(0) 1(0) 0.025 0(0) 0(0)
Genotype Female Res. Female Sus. Chi Test Male Res. Male Sus. Chi Test
Obs(Exp) Obs(Exp) Obs(Exp) Obs(Exp)
295 18(20) 22(25) 0.468
282* 1(9) 10(11) 0.010
275 0(1) 0(2) 0.074
270 0(0) 0(0) 0.371
295-295 0(0) 0(0) 36(36) 36(34) 0.766
295-282 8(0) 4(0) 11(13) 12(13) 0.506
295-275 2(0) 1(0) 2(1) 0(1) 0.128
282-282 0(0) 0(0) 3(1) 1(1) 0.107
282/275 1(0) 0(0)
295/270 0(0) 1(0)
 Res Susc.
Haplotype Obs(Exp) Obs(Exp) ChiTest
175-224 1(0) 0(1) 0.27
175-228 1(0) 0(1) 0.27
179-220 1(1) 1(1) 0.89
179-224 3(4) 6(5) 0.48
179-228 17(18) 22(21) 0.85
179-256 1(1) 1(1) 0.89
195-225 48(44) 50(54) 0.44
195-228 74(78) 98(94) 0.59
Res Susc.
Haplotype Obs(Exp) Obs(Exp) ChiTest
242-244* 3(9) 14(9) 0.01
270-249 3(6) 8(6) 0.13
266-249 6(8) 9(8) 0.44
266-244 3(4) 5(4) 0.48
274-239 0(1) 2(1) 0.16
270-244 1(2) 2(2) 0.56
266-259 0(1) 1(1) 0.32
246-259 2(2) 2(2) 1.00
246-249 15(15) 15(15) 1.00
242-239 1(1) 1(1) 1.00
246-244 3(3) 2(3) 0.65
274-259 2(2) 1(2) 0.56
262-259 1(1) 0(1) 0.32
262-249 1(1) 0(1) 0.32
270-259 2(1) 0(1) 0.16
274-244 5(4) 3(4) 0.48
274-249 18(16) 13(16) 0.37
242-249 22(20) 17(20) 0.42
242-259 16(13) 9(13) 0.16
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Table 10. Alleles for homozygous 
individuals were combined into probable 
haplotypes for PHS118 and PHS126 at 
Gga1:20 Mbp. Abbreviations and columns 
are as in the legend in Table 9.
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Table 11. Alleles for homozygous 
individuals were combined into probable 
haplotypes for PHS015 and 
PHS009.Abbreviations and columns are as in 
the legend to Table 9.
 Res Susc
Haplotype Obs(Exp) Obs(Exp) Chitest
277-161 64(68) 79(75) 0.55
277-151 4(8) 12(8) 0.07
275-161 52(42) 36(46) 0.03
275-151 3(4) 5(4) 0.58
267-161 5(8) 12(9) 0.14
267-151 8(8) 8(8) 0.82
 Res Sus
Haplotype Obs(Exp) Obs(Exp) Chitest
161-277 42(45) 59(56) 0.55
151-277 9(11) 16(14) 0.39
151-267 1(3) 5(3) 0.17
167-267 0(1) 3(2) 0.12
167-277 3(2) 2(3) 0.49
161-267 12(11) 13(14) 0.73
167-275 2(1) 0(1) 0.11
161-275 11(9) 9(11) 0.35
151-275 18(15) 15(18) 0.25
Table 12. Alleles for homozygous 
individuals were combined into probable 
haplotypes for PHS009 and PHS010. 
Abbreviations and columns are as in the 
legend to Table 9.
     
Res Susc.
Haplotype Obs(Exp) Obs(Exp) ChiTest
180-155* 25(32) 40(33) 0.08
180-157 4(5) 7(6) 0.39
180-153 6(7) 8(7) 0.63
196-157 1(1) 2(2) 0.58
180-147 19(19) 20(20) 0.95
196-153 5(4) 3(4) 0.45
180-139 14(12) 11(13) 0.50
196-147 18(16) 15(17) 0.54
196-139 13(10) 8(11) 0.25
196-155 23(20) 18(21) 0.38
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Table 14. Alleles for homozygous 
individuals were combined into probable 
haplotypes for PHS094 and PHS051. 
Abbreviations and columns are as in the 
legend in Table 9.
 Res Susc.
Haplotype Obs(Exp) Obs(Exp) ChiTest
146-181 18(15) 10(13) 0.24
146-187 30(31) 29(28) 0.71
146-191 12(11) 9(10) 0.72
150-181 12(10) 6(8) 0.25
150-187 21(21) 19(19) 0.92
150-191* 5(10) 13(8) 0.03
Table 13. Alleles for homozygous 
individuals were combined into probable 
haplotypes for PHS152 and PHS001. 
Abbreviations and columns are as in the 
legend in Table 9.
 Chapter 4: Using VNTRs to examine gene flow and multiple paternity in the 
Timber rattlesnake Crotalus horridus
    INTRODUCTION
      In addition to serving as biomarkers for disease, the use of VNTRs for gene flow and 
isolation studies in threatened and endangered species is becoming increasingly prevalent in 
the conservation biologist’s tool kit. Scientists can use VNTRs to identify familial 
relationships among capture and release populations of animals, survey the genetic variability 
of an area, and identify multiple paternity (Selkoe 2006, McDowall 2008, Narain 2000, 
Hoekert 2002). The guidelines by which policy is made to protect threatened and endangered 
animals can be better defined with higher quality population genetic information for the 
animals under focus.
    The Timber rattlesnake, Crotalus horridus, is found widely across the Eastern half of the 
United States and historically ranges from lower Ontario and Minnesota into Florida and 
Texas (Brown 1993). Populations are becoming increasingly fragmented due in large part to 
human encroachment, captures, and den compromises (A.M. Clark 2003, Reinert 1999).  The 
Timber rattlesnake is reported to be an animal of rigorous den fidelity, not straying much 
farther than 2 or 3 miles from a den site and returning to the same den each season for 
communal hibernation (Shine 2008). Males tend to forage in wider areas than females for 
both food and mates but typically remain inside a range (Shine 2008, Bonnet 1998). These 
viviparous animals typically live 20-25 years and pay a high cost for reproduction (Shine 
2008, Gardner-Santana 2009). The snakes are especially vulnerable in the spring as they 
emerge from hibernation with major negative affects being den destruction and adult capture 
(Bonnet 1998). The Timber rattlesnake has been extensively studied in the Northeastern 
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region of the United States due to its increasingly endangered status (Brown 1982, Aldridge 
1995, Reinert 1999, Furman 2007). It is listed as declining or extirpated in all New England 
states and is generally considered to be in decline in all states where it can be found (Clark 
2008).   The Timber rattlesnake can be found from the plains of Kansas, (Fitch 2004) to the 
Appalachian mountains, (Martin 1993) to the Northeastern region of the United States 
(Reinert 1999). Suitable habitats for Timber rattlesnakes are being rapidly encroached upon 
by urbanization (Laidig 2004) and hunting for sport or out of fear remains problematic 
(Furman 2007). The remaining habitat areas are being fragmented, which may be 
problematic for these philopatric snakes (Clark 2007). The Timber rattlesnake is known to 
forage widely for food, but is predominantly an ambush predator. Males are also commonly 
mobile over wide areas while seeking mates and indeed have been linked to gene flow among 
den populations (Clark 2008).  Aside from the summer months when mates are being sought 
and years when food availability is limited, timber rattlesnakes are often somewhat invisible 
to the human population. There is some consensus that males are far more mobile than 
females (Shine 2008, Bonnet 1998). Moreover, the inconsistent and often sparse movement 
of these animals leads to little human interaction and typically results in sampling of groups 
of animals found in overwintering and communal basking sites (Shine 2008). Directed 
molecular analysis of large populations of snakes could be effective in determining the 
microevolutionary processes and trends of gene flow between and among dens (Manier 2006, 
Storfer 1998, Blouin-Demers 2002, Holycross 2002, Clark 2008).
        In 2008, 373 timber rattlesnakes from 14 hibernacula in New York were genotyped 
using nine microsatellite (VNTR) loci (Clark 2008). Genotype data were used to gauge gene 
flow between and among the adjacent hibernacula in the study (average distance between 
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hibernacula was 3.2 km). The results suggest that individual movements were more 
important for genetic structure than geography and elucidated the importance of movement 
corridors for the animals in active seasons of the year.  Bushar et al. (1998) used VNTR 
genotypes to implicate population structure over kilometer distances as critical determinants 
of basking sites and communal dens. VNTR analyses of the Massasauga rattlesnake in the 
northeast United States and Ontario identified fine-scale population structure among 
populations <50 kilometers apart (Gibbs 1997). A population of northern water snakes in 
Ontario was analyzed with VNTRs in 1999 (Prosser 1999). Microgeographic genetic 
structure between populations <2 km apart was identified using deviation from expected 
heterozygote frequencies. 
    Genetically motivated study of the Timber rattlesnake may lead to more informed 
conservation efforts and “nuisance animal” strategies. Currently, wildlife management 
personnel utilize short distance wildlife translocation as a humane alternative to 
exterminating wildlife that impedes human activity (Brown 2009). Brown et al conducted a 
year-long study on Western rattlesnakes in an effort to determine if short distance (500m) 
relocation of the animals had detrimental effects. They concluded there was increased 
overall activity and movement in the relocated animals, but those relocated to “high-
quality” habitats suffered no adverse effects. In a conflicting report, there is evidence that 
“capture and release” is ineffectual as a relocation practice for Timber rattlesnakes when 
they are encountered by humans (Reinert 1999). Reinert et al found that the snakes in their 
study had difficulty establishing in a new hibernacula and displayed abnormally high 
overwintering mortality rates. 
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     We have been studying a set of capture areas that range over approximately 5,666 ha at 
the Bear Hollow Natural Area, the Ozark Natural Science Center, and the Madison County 
Wildlife Management Area (WMA) (Gardner-Santana 2009). The geography of the WMA 
is such that animals are not geographically isolated and are able to travel from one site to 
another, but distances from the opposite ends of the sample area could be considered 
limiting and may represent boundaries for gene flow. Characterization of the normal gene 
flow and population structure for Timber rattlesnakes may aid in identification of more 
successful ways to preserve, handle, and reintroduce these animals to protected lands.
         The use of VNTR interrogation of our population of snakes, particularly in litters of 
captive born animals along with mothers, also allowed us to use the VNTR loci to examine 
whether there is multiple paternity within a single litter. Timber rattlesnake females are 
known to store sperm over the winter (Aldridge 1995). Copulation with multiple males is 
also commonly observed (Gibbs 2001). Thus these snakes may exhibit multiple paternity in a 
litter. Multiple paternity is well documented in snakes,  (McCracken 1999, King 2001, 
Garner 2002), tortoises (Johnston 2006), lizards (Gullberg 1997), turtles (Pearse 2002),and 
salamanders (Adams 2005) but no reports of multiple paternity have been made for the 
Timber rattlesnake.  We provide evidence here of multiple paternity at two of our three 
VNTR loci. 
METHODS 
Sampling and Populations: A population of 186 animals in the WMA was divided into 8 
sub-groups: 6 sub-groups within the wildlife management area (Groups A1-D2), 1 group of 
35 animals from outside the management area but within the state of Arkansas (AR), and 
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one group of 22 diverse samples from Mississippi, Illinois, and Virginia (US) (Figure 1, 
Table 1). 
      For multiple paternity, all litters were born in captivity. We collected blood for 
maternal alleles on 3 groups, 4 groups have no sampled mother. All were sampled via shed 
skin or blood isolation method.
Isolation of DNA from Shed Skin:  Skin samples were homogenized in 5 ml TE (10 mM 
TrisCl, 1mM EDTA, pH 7.5) per gram of tissue using a Tissue-Tearor tissue homogenizer. 
The homogenate was brought to 0.5% SDS, and 100μg/mL each RNAseA and Pronase E. 
After incubation for 30 minutes at 37°C, the solution was extracted once with 
phenol:chloroform:isoamyl alcohol (125:24:1), then once with chloroform:IAA (24:1). 
DNA was precipitated with ethanol and rehydrated. All DNAs were dissolved in Te (10 
mM TrisCl, 0.1mM EDTA, pH 7.5) and stored frozen at -20°C.
 Isolation of DNA from Blood:  DNA isolation followed the method of Bailes 2007.
Polymerase Chain Reaction: PCR was typically performed in 96 well plates using either 
an MJ Research PTC-100 Programmable Thermal Controller Thermocycler or an 
Eppendorf  Mastercycler Gradient. Reactions of 20ul contained 1X Taq Buffer (50 mM 
Tris-Cl, pH 8.3, 1 mM MgCl2, 30μg/ml BSA), 0.2 mM dNTPs, 0.4 μM each forward and 
reverse primers, 2.5 units Taq polymerase, and 2 μl of  DNA (approx. 50 ng). PCR 
conditions were an initial denaturation at 90° C for 1 minute followed by 40-45 cycles of 
90° C for 25 s, 30 s anneal at 56, 53, or 50° C (Table 2), 72° C for 60 s, and a final 
extension at 72° C for 3 minutes.
Gel Electrophoresis:  PCR products were resolved in 6% denaturing polyacrylamide gels 
(38:2 acrylamide:MBA, 50% urea) in 1xTEB (100 mM Tris, 10 mM boric acid, 2 mM 
65
EDTA, pH9.2). PCR product (2μl) was mixed with 5ul loading buffer (95% Formamide, 
1X TEB, 0.02% Bromophenol Blue). Samples were heat denatured at 90° C for 5 minutes, 
quick-chilled on ice then 1-2 μl was loaded to a lane. CXR ladder (Promega Corp.) was 
used as size marker. 
Gel Imaging: Gels were scanned with a Model 9600 Typhoon imager (GE Health Care) 
and images analyzed using ImageQuant software. 
Statistical Analysis:  Genotype data was assembled in groups as specified above and 
analyzed with Genepop (www.genepop.curtin.edu.au) for allele diversity, genotype 
diversity, and Fst based on geographic versus genetic distance. 
RESULTS
    For our gene flow study, we used three established primer pairs, 5-183, CwB6, and 
CwD15 (Villareal 1996, Holycross et al, 2002). All primer pairs were polymorphic, with 
5-183 amplifying 5 alleles of 126-142 bp, CwB6 amplifying 11 alleles of 96-116 bp, and 
CwD15 amplifying 3 alleles of 124-133 bp (Table 3). We analyzed the sub-groups and the 
out-groups in a pair-wise manner to compare the ability of our VNTR markers to 
differentiate populations. Each population was analyzed for adherence to Hardy-Weinberg 
equilibrium (HWE) by calculation of Chi-square values comparing observed allele 
frequencies to expected allele frequencies for each locus for each sub-group (Table 4). The 
entire Arkansas population (A1-D2) was analyzed in paired sub-groups for allele and 
genotype differences. We also compared each sub-group to two out-groups, AR and US 
(Tables 5-10).  
     In the whole population, primer pair 5-183 amplified 5 alleles from 179 individuals with 
allele sizes ranging from 128 to 142 bp (Table 3).  The heterozygote frequency was 0.64 
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(Table 2). The allele frequencies for all groups, when analyzed independently, were in 
equilibrium except for the B and the US groups (Table 4). We analyzed our samples for 
allelic differentiation between each sub-group and the two out-groups. Primer pair 5-183 
showed significant difference between the US out-group and all but two sub-groups; A1 
and C (P≤0.03) (Table 5). Sub-group B was different from D1, D2, AR, and US sub-groups 
(P≤0.04). Sub-group A2 was significantly different than groups D2 and US (P≤0.03). Sub-
group A1 was significantly different from groups B and D1 (P≤0.02). We also analyzed 
each sub-group for genotypic difference when compared to all other sub-groups (Table 6). 
The US sub-group was significantly different from the B, D1, and AR sub-groups 
(P≤0.03). The sub-group A1 was significantly different than the B, D1, and D2 groups 
(P≤0.03). 
    Primer pair CwB6 amplified 11 alleles from 217 individuals. Heterozygote frequency 
was 0.59 and allele sizes ranged from 96 to 128 bp (Tables 2 and 3). This primer pair 
amplified alleles that did not conform to HWE for 6 of 8 sub-groups (Table 4). When 
analyzed for allelic difference between sub-groups (Table 7), this locus showed a 
significant difference between D1 and A1 (P=0.02). There was a significant difference 
between the AR sub-group and the A2 and B sub-groups (P≤0.0009). We also analyzed the 
sub-groups for genotypic difference (Table 8). The B and AR sub-groups differed 
significantly (P=0.04).
    CwD15 amplified 3 alleles from only 104 individuals with allele sizes of 124-133 bp 
(Table 3).  The heterozygote frequency was 0.40 (Table 2). All subgroups were within 
HWE for CwD15 (Table 4). For allelic frequencies (Table 9) sub-group A2 was 
significantly different when compared to sub-groups A1, B, D1, and AR (P≤0.02). There 
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was also a significant difference between sub-group B when compared to C and to the US 
out-group (P≤0.05). This locus was also analyzed for genotypic difference between sub-
groups (Table 10). Sub-group A2 significantly differed from the B, AR, and US sub-groups 
(P≤0.05).
    In an effort to determine the power of these 3 primer pairs to amplify significant and 
unique alleles across our sub-groups, we performed an Fst pairwise analysis (Weir 1983). 
When computed relative to geographic distance, we found no significant difference for any 
pair of sub-groups (P=0.99) (Data not shown).
    For investigation of multiple paternity, we analyzed 7 separate litters of snakes whose 
location within or outside the WMA are known (Table 11); for three litters we know the 
mother and she is in our dataset.  For four litters, the mother is not known. Of the groups 
with a sampled mother, two are from Arkansas, but outside the WMA, while one is from 
within the WMA. Of the four litters of siblings with no mother, 3 are from within the 
WMA and one is from Arkansas, outside the WMA. We genotyped all litters for these 
three loci and determined how many alleles were present in each litter for each locus.  
    For litter 1, primer pair 5-183 two alleles were amplified, 136 bp and 128 bp. The 
mother was heterozygous for these two alleles, 128/136. Two offspring were homozygous, 
one 128/128 and one 136/136. The other 3 offspring were heterozygous, 128/136.  Four 
alleles were amplified with primer pair CwB6, (110, 108, 106, and 104 bp). The mother has 
a genotype 110/108. All five offspring were heterozygous (110/104 or 108/106). For locus 
CwD15 only one allele was amplified (124 bp). 
    For litter 2, locus 5-183, four alleles were detected, 128, 130, 136, and 142 bp. The 
mother was heterozygous 136/128; four offspring were heterozygous with genotypes of 
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142/136, 136/128, 136/130, or 130/128. Five offspring were homozygous; 128/128 or 
136/136. CwB6 amplified five alleles (114 bp, 110 bp, 108 bp, 106 bp, and 104 bp). All 
offspring at this locus were heterozygous (110/108, 110/104, or 110/106). The mother was 
heterozygous (110/108). All individuals were homozygous for the 124 bp allele for locus 
CwD15. At locus CwB6, this group of animals had 4 individuals that could not be 
correlated with either maternal allele, likely due to genotypes that included artifacts. So this 
data set has been excluded until the mother and offspring can be resolved unambiguously. 
    For litter 3, all individuals contained at least one maternal allele for each locus.  Primer 
pair 5-183 amplified 2 alleles (128 bp, 136 bp). Four offspring of were heterozygous 
(136/128) and one each was homozygous (128/128 and 136/136). Primer pair CwB6 
amplified 4 alleles for litter 3 (110, 108, 106, and 104 bp). The mother was heterozygous 
106/104. Five offspring were heterozygous (108/104, 110/106, or 110/104) and 1 was 
homozygous (106/106).  CwD15 was inconclusive as several individuals failed to amplify 
in multiple PCRs.  
    For sibling group 1 (mother unknown), primer pair 5-183 amplified 2 alleles (136 bp, 128 
bp) for 4 out of 5 siblings.  Three were heterozygous (136/128) and one was homozygous 
(128/128). Primer pair CwB6 amplified 3 alleles for 4 of 5 animals (112 bp, 110 bp, 102 bp). 
All animals were heterozygous (110/102, 112/110, or 110/102). We were able to genotype 
only one animal in this group with CwD15.  
    For sibling group 2, primer pair 5-183 amplified 2 alleles (136 bp and 128 bp). Three 
animals were homozygous (136/136) and one was heterozygous (136/128). Primer pair 
CwB6 amplified two alleles.  All individuals were heterozygous 130/114 at this locus. 
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CwD15 amplified two alleles in this group (124 bp and 130 bp). One animal was 
heterozygous; the other three were homozygous (124/124). 
  For sibling group 3, primer pair 5-183 amplified 3 alleles (128 bp, 130 bp, and 136 bp). 
Two individuals were heterozygous for genotype 136/128, one was heterozygous for 
136/130, and one was homozygous 128/128. CwB6 amplified 4 alleles (118 bp, 114 bp, 110 
bp, and 102 bp). All individuals were heterozygous (118/114, 114/102, 114/110, 114/112). 
CwD15 was monomorphic; all individuals were homozygous 124/124.
    For sibling group 4, primer pair 5-183 amplified 2 alleles (128 bp and 136 bp). Both 
individuals were homozygous, one with the genotype 136/136 and one with 128/128. CwB6 
amplified 2 alleles, 114 bp and 112 bp. Both individuals were heterozygous with a genotype 
114/112. CwD15 also amplified 2 alleles, 130 bp and 124 bp. Both individuals were 
heterozygous with the genotype 130/124.
DISCUSSION
Gene Flow
     The use of VNTR analysis to determine population structure and gene flow is 
increasingly popular in conservation ecology (Selkoe 2006). Genetic analysis can 
complement field studies and allow for better conservation practices and management 
plans (Clark 2007, Ciofi 1999 and 2002, Calsbeek 2007, Prior 1997, Dever 2002). We 
applied VNTR analysis to our population in an effort to distinguish population structure 
and elucidate any patterns in gene flow.
      The 18 animals from the US group from outside the state that could be genotyped were 
significantly different from every sub-group in Arkansas except the A1, A2, and the C 
groups which represent only 11 of the 179 individuals that could be genotyped for this 
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locus. This difference between groups may indicate that 5-183 is a useful marker for testing 
geographic isolation and gene flow. Furthermore, locus 5-183 amplified alleles that 
displayed sufficient diversity and maintained HWE in a Hardy Weinberg Exact test (Guo 
1992), suggesting adequate sampling and normal gene flow within the populations. Our 
analysis of the Arkansas population, when compared to the animals from outside the state, 
showed a significant difference in the frequency of alleles and genotypes at locus 5-183. 
Primer pair CwB6, while amplifying more alleles than 5-183, was not in HWE for nearly 
every sub-group. This could be sampling bias or more likely evidence that some of the 
alleles may be artifactual PCR products.  CwD15 is consistently in HWE, but lacks 
diversity sufficient to distinguish populations. All primer pairs were able to differentiate 
sub-groups by allele and/or genotype comparison, especially when comparing the Arkansas 
animals to those from outside Arkansas. However, within the WMA population, these loci 
fail to detect any finer population structure.  This could mean that there is adequate gene 
flow within the WMA population, or that three loci with a small number of alleles are 
insufficient to detect subpopulations. In a study of the Galápagos tortoise on the Galápagos 
islands, VNTR analysis was used to describe genetic diversity and structure among and 
between the islands (Ciofi 2002). Our study aims to describe the diversity among our 
Arkansas population and compare it to populations of known geographic origin outside 
Arkansas and to a geographically separate population inside Arkansas.  A finer analysis of 
this population of animals with respect to gene flow and population structure could be 
possible using more loci possibly with greater allelic diversity. The majority of VNTR 
analyses that well-define population structure appear to address the population at multiple 
polymorphic loci (Clark 2007, Dever 2002, Ciofi 1999 and 2002). In a study comparing 
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hibernacula of black rat snakes, 14 randomly amplified polymorphic DNA (RAPD) regions 
were used to determine population structure (Prior 2000). Fst analysis was able to show 
genetic variation was highest between individual animals in the study, though some 
significance was shown between their sub-populations.  In a more robust study, 
microsatellite [VNTR] analysis revealed an important link between seasonal male dispersal 
and gene flow between hibernacula of Timber rattlesnakes in the Northeastern United 
States (Clark 2007).  Few studies have been undertaken for population structure in the 
Timber rattlesnake. Our populations’ high individual count, well characterized den sites, 
and frequent recapture will allow us to learn much about the way genes are disseminated in 
the Arkansas population of Timber rattlesnakes in the Ozark Mountains. 
Multiple Paternity
   Multiple paternity occurs due to mating with multiple males within single reproductive 
cycle or mating with one or multiple males across multiple reproductive cycles and storing 
sperm (Uller 2008). Multiple paternity is frequently reported in reptiles and is particularly 
common in snakes and lizards (Uller 2008). Many methods have been employed for multiple 
paternity verification in reptiles; microsatellite [VNTR] analysis, DNA fingerprinting, and 
RFLP amplification (Uller 2008). Our analysis for multiple paternity used VNTR genotyping 
and was based almost exclusively on genotypes at locus CwB6. Locus CwD15 amplified 
only two alleles and did so sporadically. Our analysis of captive-born families allows us to 
confidently eliminate maternal alleles from the genotypes of the offspring and accurately 
(within the power of our marker) assign alleles to a prospective father or fathers. 
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    For mother known litter 1, when genotyped with 5-183 there is no evidence of more than 
two paternal alleles, 128 and 136. For CwB6our data identifies only two paternal alleles, 104 
and 106. No conclusions can be drawn for CwD15.
    For mother known litter 2, paternal alleles of 142 bp and 130 bp can be assigned for primer 
pair 5-183. For CwB6, we have evidence of multiple paternity with the presence of three 
alleles (108 bp, 106 bp, and 104 bp) that cannot be contributed by the mother. No 
conclusions can be drawn from CwD15. 
    For mother known group #3, no conclusions can be drawn for 5-183 or CwD15. CwB6 
amplified three alleles (110 bp, 108 bp, and 106 bp) that cannot be contributed by the mother. 
These findings support multiple paternity in our group of Timber rattlesnakes.
    Sibling groups #1 through #4 show no evidence of multiple paternity.
    There is currently no record in the literature of multiple paternity being reported in Timber 
rattlesnakes. As such, we will replicate these data both biologically and methodologically to 
ensure our report is complete. To that end, we will also interrogate more loci for multiple 
paternity testing. Indeed, in 2000 a study showed that the use of 6 polymorphic 
microsatellites [VNTR] had the power of 159 AFLP when determining paternity (Gerber 
2000).
    In summary, our data support the use of locus 5-183 for population genetics studies of 
Timber rattlesnakes, but with limited ability to identify discrete populations within a small 
geographic area. Locus CwB6, while reported to be highly polymorphic and useful for 
analysis of small geographic areas, proved insufficient in our analysis. CwD15 has 
insufficient diversity for use as a marker in gene flow analysis for isolated populations.     
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    The primer pair CwB6 was useful for multiple paternity studies as the level of 
polymorphism allows successful identification of maternal alleles. However, due to its lack 
of conformation to Hardy-Weinberg Equilibrium and the presence of artifactual alleles, these 
findings require further investigation.  Our continued efforts will utilize 5-183 and CwB6 to 
genotype and analyze more captivity-born families. We are currently optimizing published 
VNTR sites for further analysis.
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Figure 1. Capture sites in the Northwest Arkansas Wildlife 
Management Area. Areas grouped for our gene flow analysis are 
designated by a dashed line (A1-D2). Capture group areas are indicated 
with shaded areas and pins indicate catch sites.
250 m
             
A2 B C D1 D2
A1 247.8 459.6 1052.8 1115.0 1362.5
A2 371.6 758.6 867.2 1130.2
B 507.8 459.6 805.0
C 433.4 464.5
D1 396.2
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Locus Allele (bp) A1 A2 B C D1 D2 AR US
5-183 142 0(3) 0(1) 11(7) 3(2) 11(8) 0(1) 4(5) 1(3)
140 4(6) 3(2) 25(16) 5(5) 15(17) 2(2) 7(10) 2(6)
136 18(11) 5(4) 22(30) 10(9) 31(31) 4(4) 19(18) 10(11)
130 3(6) 2(2) 10(16) 4(5) 23(17) 5(2) 14(10) 2(6)
126 11(10) 2(3) 26(26) 8(8) 20(27) 1(3) 14(16) 21(10)
CwB6 116 8(6) 5(2) 18(14) 1(5) 15(15) 2(2) 3(7) 4(5)
112 7(5) 1(2) 7(12) 5(5) 14(13) 1(2) 8(7) 6(4)
110 10(11) 1(4) 25(26) 12(10) 32(28) 1(3) 16(14) 9(9)
106 1(3) 0(1) 4(8) 8(3) 9(8) 0(1) 5(4) 4(3)
118 0(2) 1(1) 8(5) 2(2) 4(5) 1(1) 2(3) 3(2)
114 6(5) 4(2) 16(13) 2(5) 14(13) 3(2) 4(7) 2(5)
108 11(9) 4(3) 23(20) 6(8) 16(21) 2(3) 10(11) 9(7)
104 1(2) 0(1) 3(5) 4(2) 5(6) 1(1) 8(3) 0(2)
102 4(2) 0(1) 2(5) 2(2) 7(5) 1(1) 4(3) 1(2)
128 0(1) 0(0) 4(1) 2(1) 0(2) 0(0) 0(1) 0(1)
96 0(1) 0(0) 1(2) 0(1) 2(2) 2(0) 0(1) 2(1)
CwD15 133 4(3) 2(0) 2(5) 3(1) 2(5) 1(1) 2(2) 4(3)
130 3(4) 2(1) 6(9) 3(2) 9(8) 1(1) 4(3) 7(5)
124 19(19) 0(3) 48(41) 8(10) 39(37) 6(6) 16(15) 19(22)
Table 1. Geographic distances 
between the centers of capture regions 
of sub-groups inside the WMA in 
meters.
Table 2. Allele counts for all sub-groups. The alleles (bp) amplified by each primer pair 
(Locus) were tabulated for each sub-group (A1-US) and observed (Obs) versus expected 
(Exp) counts were compared.
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Primer Sequence (5' to 3') VNTR # Alleles Size (bp)
Annealing T 
(C°)
Heterozygote 
frequency
5-183 TTGTTGTAACCAGTGTGTGTGAT (CA)11 5 128-142 50 0.64
CTGCAGACACTTATTATTATACC
CwB6 CTCTTTTACGCCCACCACTTTA (GA)19 11 96-128 56 0.59
CCCCGCTAACCTTTGCTCAG
CwD15 TAATGTTGTAAGCCACCTAGAAT (CAT)(TAT)(CAT)14 3 124-133 53 0.40
TTCTTCAAAGCACATAACACATC
Table 3. VNTR primer pairs: 5-183 (Villareal et al., 1996), CwB6 and CwD15 (Holycross 
et al, 2002) with sequence information, the repeat amplified (VNTR), number of alleles 
amplified (bp), optimized annealing temperature, and the calculated heterozygote 
frequency. 
5-183 CwB6 CwD15
A1 0.07 0.00 0.17
A2 0.47 0.20 1.00
B 0.00 0.00 0.25
C 0.08 0.01 0.52
D1 0.35 0.00 0.32
D2 0.36 0.54 1.00
AR 0.15 0.00 0.66
US 0.05 0.01 0.68
Table 4. Hardy-Weinberg Equilibrium 
Probability Test for each group (A1-OTHER) 
at each locus (5-183, CwB6, and CwD15). 
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N A2 B C D1 D2 AR US
A1 18 0.460 *0.01 0.260 *0.02 0.260 0.120 0.100
A2 6 0.510 0.810 0.740 *0.03 0.690 *0.03
B 47 0.720 *0.04 *0.04 *0.04 *0.003
C 5 0.820 0.280 0.790 0.070
D1 50 0.560 0.890 *0.0003
D2 6 0.600 *0.0002
AR 18 *0.01
US 29
N A2 B C D1 D2 AR US
A1 18 0.490 *0.02 0.200 *0.02 *0.03 0.090 0.090
A2 6 0.570 0.240 0.620 0.580 0.680 0.060
B 47 0.850 0.100 0.120 0.130 *0.02
C 5 0.840 0.250 0.230 0.150
D1 50 0.480 0.910 *0.001
D2 6 0.560 0.006
AR 18 *0.03
US 29
Table 6. Genotype differentiation between all sub-
groups for marker 5-183. The size of the sub-groups 
are given (N). P-values indicating significant 
differences between sub-groups are indicated (*). 
Table 5. Allelic differentiation between groups at 
locus 5-183. Sub-group size is noted (N). P-values of P 
≤0.05 for significantly different combinations of sub-
groups within the WMA are indicated (*). 
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N A2 B C D1 D2 AR US
A1 24 0.380 0.350 0.770 0.560 0.780 0.520 0.460
A2 8 0.770 0.240 0.260 0.960 0.070 0.240
B 54 0.280 0.340 0.850 *0.04 0.500
C 19 0.760 0.530 0.230 0.980
D1 57 0.850 0.710 0.790
D2 6 0.730 0.500
AR 19 0.320
US 30
Table 8. Genotypic differentiation between all 
sub-groups for marker CwB6. Columns and 
labels are as in Table 5.
Table 7. Allelic differentiation between groups at 
locus CwB6. Columns and labels are as in Table 4.
N A2 B C D1 D2 AR US
A1 24 0.340 0.240 0.500 *0.02 0.500 0.310 0.290
A2 8 0.730 0.190 0.120 0.500 *0.0009 0.120
B 54 0.090 0.180 0.450 *0.0006 0.290
C 19 0.790 0.510 0.160 0.920
D1 57 0.410 0.590 0.071
D2 6 0.220 0.021
AR 19 0.150
US 30
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Table 9. Allelic differentiation between groups at 
locus CwD15. Columns and labels are as in Table 4.
N A2 B C D1 D2 AR US
A1 13 0.060 0.220 0.660 0.240 1.000 0.770 0.460
A2 2 *0.006 0.250 0.960 0.130 *0.05 *0.05
B 28 0.080 0.660 0.700 0.470 0.070
C 7 0.180 0.700 0.740 0.770
D1 25 1.000 0.710 0.260
D2 4 1.000 0.820
AR 15 0.900
US 10
Table 10. Genotypic differentiation between all groups 
for marker CwD15. Columns and labels are as in Table 
5.
N A2 B C D1 D2 AR US
A1 13 *0.01 0.130 0.550 0.220 0.550 0.720 0.052
A2 2 *0.0004 0.140 *0.0003 1.000 *0.02 *0.04
B 28 *0.02 0.560 0.490 0.190 *0.05
C 7 0.090 1.000 0.700 0.810
D1 25 0.570 0.580 0.260
D2 4 1.000 0.850
AR 15 1.000
US 10
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ID SITE 5-183 CwB6 CwD15
Group 1
MOM#1 AR-O 136 128 110 108 124 124
OS1-1 AR-O 136 128 108 106 124 124
OS1-1 AR-O 136 128 110 104 124 124
OS3-1 AR-O 136 128 108 106 124 124
OS4-1 AR-O 136 136 108 106 124 124
OS5-1 AR-O 128 128 110 104 124 124
Group 2
MOM#2 AR-O 136 128 114 110 ? ?
OS1-2 AR-O 142 136 110 108 130 124
OS2-2 AR-O 136 136 104 102 130 124
OS3-2 AR-O 136 128 110 104 124 124
OS4-2 AR-O 128 128 104 102 124 124
OS5-2 AR-O 136 130 110 106 124 124
OS6-2 AR-O 136 136 110 104 ? ?
OS7-2 AR-O 128 128 104 104 130 124
OS8-2 AR-O 128 128 110 108 ? ?
OS9-2 AR-O 130 128 118 106 124 124
Group 3
MOM#3 C 136 128 106 104 ? ?
OS1-3 C 136 128 108 104 130 124
OS2-3 C 136 128 110 106 ? ?
OS3-3 C 136 128 110 104 ? ?
OS4-3 C 136 136 110 104 ? ?
OS5-3 C 136 128 106 106 ? ?
OS6-3 C 128 128 110 106 ? ?
Group 4
SIB1-1 AR-O 136 128 110 102 124 124
SIB2-1 AR-O 128 128 112 110 ? ?
SIB3-1 AR-O 136 128 110 102 ? ?
SIB4-1 AR-O 136 128 ? ? ? ?
SIB5-1 AR-O ? ? 112 110 ? ?
Group 5
SIB1-2 B 136 136 130 114 124 124
SIB2-2 B 136 136 130 114 130 124
SIB3-2 B 136 128 130 114 124 124
SIB4-2 B 136 136 130 114 124 124
Group 6
SIB1-3 D1 136 130 118 114 124 124
SIB2-3 D1 128 128 114 102 124 124
SIB3-3 D1 136 128 114 110 124 124
SIB4-3 D1 136 128 114 112 124 124
Group 7
SIB1-4 D1 136 136 114 112 130 124
SIB2-4 D1 128 128 114 112 130 124
Table 11. Familial analysis for multiple 
paternity at three VNTR loci (5-183, 
CwB6, and CwD15) for 3 maternal-
inclusive groups (ID). OS#-# indicates 
offspring. Four groups of siblings only are 
represented (SIB#-#).
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CONCLUSION
    It is useful to utilize VNTR genotyping as a tool to point the way toward regions on 
chromosomes are important to the biology of an organism. While seldom contributive to a 
phenotype, these biomarkers are often road signs to allow for successful description of 
complex systems or the evolution of a species.
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